[ {
  "answer" : "**Answer:**  \nThe graph shows that Ropinirole is indicated for three conditions: parkinsonian disorder (MONDO:0021095), Parkinson disease (MONDO:0005180), and restless legs syndrome (MONDO:0005391).\n\n**Evidence**  \n- parkinsonian disorder (MONDO:0021095)  \n- Parkinson disease (MONDO:0005180)  \n- restless legs syndrome (MONDO:0005391)\n\n**Details**\n\n| Disorder ID | Disorder Name          |\n|-------------|------------------------|\n| MONDO:0021095 | parkinsonian disorder |\n| MONDO:0005180 | Parkinson disease     |\n| MONDO:0005391 | restless legs syndrome |",
  "context" : "[{\"disorderId\": \"mondo.0021095\", \"disorderName\": \"parkinsonian disorder\"}, {\"disorderId\": \"mondo.0005391\", \"disorderName\": \"restless legs syndrome\"}, {\"disorderId\": \"mondo.0005180\", \"disorderName\": \"Parkinson disease\"}]",
  "cypher" : "MATCH (d:Drug)-[:DrugHasIndication]->(dis:Disorder)\nWHERE toLower(d.displayName) = toLower('Ropinirole')\nRETURN dis.primaryDomainId AS disorderId, dis.displayName AS disorderName;",
  "isCorrect" : false,
  "question" : "What indications are associated with the use of Ropinirole?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer**  \nThe knowledge graph links Clomipramine (DrugBank DB01242) to several serious adverse events, most of which involve loss of consciousness and cardiovascular collapse.  These events include loss or unconsciousness of consciousness, circulatory collapse, vascular collapse, shock, and cardiovascular collapse.  The data suggest that Clomipramine can produce significant neurological and cardiovascular side effects.  \n\n**Evidence**  \n- Clomipramine (DrugBank DB01242) – side effect: *Lost consciousness* (meddra.10024885)  \n- Clomipramine (DrugBank DB01242) – side effect: *Unconsciousness* (meddra.10045481)  \n- Clomipramine (DrugBank DB01242) – side effect: *Collapse circulatory* (meddra.10009909)  \n- Clomipramine (DrugBank DB01242) – side effect: *Cardiovascular collapse* (meddra.10009908)  \n- Clomipramine (DrugBank DB01242) – side effect: *Shock* (meddra.10040560)  \n\n**Details (sample)**  \n\n| Side‑Effect ID | Side‑Effect Name              |\n|----------------|------------------------------|\n| meddra.10024885 | Lost consciousness           |\n| meddra.10045481 | Unconsciousness              |\n| meddra.10009909 | Collapse circulatory         |\n| meddra.10009908 | Collapse cardiovascular      |\n| meddra.10040560 | Shock                        |\n\n*(Only a subset of the full list is shown.)*",
  "context" : "[{\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10024885\", \"sideEffectName\": \"Lost consciousness\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10010772\", \"sideEffectName\": \"Consciousness loss of\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10024855\", \"sideEffectName\": \"Loss of consciousness\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10045481\", \"sideEffectName\": \"Unconsciousness\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10045479\", \"sideEffectName\": \"Unconscious\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10010766\", \"sideEffectName\": \"Consciousness awaking loss\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009910\", \"sideEffectName\": \"Collapse circulatory peripheral\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10000692\", \"sideEffectName\": \"Acute circulatory failure\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009917\", \"sideEffectName\": \"Collapse vascular\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10007647\", \"sideEffectName\": \"Cardiovascular collapse\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10040564\", \"sideEffectName\": \"Shock circulatory\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10047052\", \"sideEffectName\": \"Vascular collapse\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009192\", \"sideEffectName\": \"Circulatory collapse\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10016161\", \"sideEffectName\": \"Failure peripheral circulatory\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009915\", \"sideEffectName\": \"Collapse peripheral vascular\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009909\", \"sideEffectName\": \"Collapse circulatory\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10040583\", \"sideEffectName\": \"Shock vascular\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10016144\", \"sideEffectName\": \"Failure circulatory\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10040560\", \"sideEffectName\": \"Shock\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10040585\", \"sideEffectName\": \"Shock, unspecified\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009908\", \"sideEffectName\": \"Collapse cardiovascular\"}, {\"drugId\": \"drugbank.DB01242\", \"drugName\": \"Clomipramine\", \"sideEffectId\": \"meddra.10009195\", \"sideEffectName\": \"Circulator... (truncated)",
  "cypher" : "MATCH (d:Drug)\nWHERE toLower(d.displayName) = toLower('Clomipramine')\nMATCH (d)-[:DrugHasSideEffect]->(se:SideEffect)\nRETURN d.primaryDomainId AS drugId, d.displayName AS drugName, se.primaryDomainId AS sideEffectId, se.displayName AS sideEffectName",
  "isCorrect" : false,
  "question" : "What are the common side effects observed with Clomipramine administration?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: The CAS registry number for Ribavirin is **36791‑04‑5**.  \nEvidence:  \n• Ribavirin (DrugBank: DB00811) – CAS number 36791‑04‑5.",
  "context" : "[{\"drugId\": \"drugbank.DB00811\", \"drugName\": \"Ribavirin\", \"casNumber\": \"36791-04-5\"}]",
  "cypher" : "MATCH (d:Drug) WHERE toLower(d.displayName) = toLower('Ribavirin') RETURN d.primaryDomainId AS drugId, d.displayName AS drugName, d.casNumber AS casNumber;",
  "isCorrect" : true,
  "question" : "What is the CAS registry number for Ribavirin?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for Donepezil, broaden the search to include related drugs or side‑effect phenotypes, or relax any query filters that may have limited the results.",
  "context" : "[]",
  "cypher" : "MATCH (d:Drug)\nWHERE toLower(d.displayName) = toLower('Donepezil')\nMATCH (d)-[:DrugHasSideEffect]->(se:SideEffect)\nWHERE se.primaryDomainId IN ['meddra.10042788','meddra.10002757','meddra.10013707','meddra.10042796','meddra.10008674']\nMATCH (se)-[:SideEffectSameAsPhenotype]->(ph:Phenotype)\nRETURN DISTINCT ph.primaryDomainId AS phenotypeId, ph.displayName AS phenotypeName",
  "isCorrect" : true,
  "question" : "What phenotypes are associated with side effects of Donepezil?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nPregabalin is known to bind three protein targets: the calcium‑channel auxiliary subunit α2δ‑2 (CA2D2_HUMAN, UniProt Q9NY47), the calcium‑channel auxiliary subunit α2δ‑1 (CA2D1_HUMAN, UniProt P54289), and the amino‑acid transporter LAT1 (LAT1_HUMAN, UniProt Q01650).  \n\n**Evidence**  \n- CA2D2_HUMAN (UniProt Q9NY47) – drug target  \n- CA2D1_HUMAN (UniProt P54289) – drug target  \n- LAT1_HUMAN (UniProt Q01650) – drug target  \n\n**Details**  \n\n| Target Name | UniProt ID |  \n|-------------|------------|  \n| CA2D2_HUMAN | Q9NY47 |  \n| CA2D1_HUMAN | P54289 |  \n| LAT1_HUMAN | Q01650 |",
  "context" : "[{\"targetId\": \"uniprot.Q9NY47\", \"targetName\": \"CA2D2_HUMAN\"}, {\"targetId\": \"uniprot.P54289\", \"targetName\": \"CA2D1_HUMAN\"}, {\"targetId\": \"uniprot.Q01650\", \"targetName\": \"LAT1_HUMAN\"}]",
  "cypher" : "MATCH (d:Drug)-[:DrugHasTarget]->(p:Protein)\nWHERE toLower(d.displayName) = toLower('Pregabalin')\nRETURN p.primaryDomainId AS targetId, p.displayName AS targetName;",
  "isCorrect" : true,
  "question" : "What are the known targets of the drug Pregabalin?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nParoxetine (DrugBank DB00715) is contraindicated in the following conditions: serotonin syndrome (MONDO 0018546), bipolar disorder (MONDO 0004985), liver disorder (MONDO 0005154), blood‑coagulation disease (MONDO 0001531), inappropriate antidiuretic hormone (ADH) syndrome (MONDO 0006802), and neuroleptic malignant syndrome (MONDO 0019790).\n\n**Evidence**  \n- Paroxetine (DrugBank DB00715) – drug  \n- Serotonin syndrome (MONDO 0018546) – contraindication  \n- Bipolar disorder (MONDO 0004985) – contraindication  \n- Liver disorder (MONDO 0005154) – contraindication  \n- Blood coagulation disease (MONDO 0001531) – contraindication  \n- Inappropriate ADH syndrome (MONDO 0006802) – contraindication  \n- Neuroleptic malignant syndrome (MONDO 0019790) – contraindication  \n\n**Details**  \n\n| Drug | Disorder | Disorder ID |\n|------|----------|-------------|\n| Paroxetine | Serotonin syndrome | MONDO 0018546 |\n| Paroxetine | Bipolar disorder | MONDO 0004985 |\n| Paroxetine | Liver disorder | MONDO 0005154 |\n| Paroxetine | Blood coagulation disease | MONDO 0001531 |\n| Paroxetine | Inappropriate ADH syndrome | MONDO 0006802 |\n| Paroxetine | Neuroleptic malignant syndrome | MONDO 0019790 |\n",
  "context" : "[{\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0018546\", \"disDisplayName\": \"serotonin syndrome\"}, {\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0004985\", \"disDisplayName\": \"bipolar disorder\"}, {\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0005154\", \"disDisplayName\": \"liver disorder\"}, {\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0001531\", \"disDisplayName\": \"blood coagulation disease\"}, {\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0006802\", \"disDisplayName\": \"inappropriate ADH syndrome\"}, {\"drugId\": \"drugbank.DB00715\", \"drugDisplayName\": \"Paroxetine\", \"disId\": \"mondo.0019790\", \"disDisplayName\": \"neuroleptic malignant syndrome\"}]",
  "cypher" : "MATCH (d:Drug)\nWHERE toLower(d.displayName) = toLower('Paroxetine')\nMATCH (d)-[:DrugHasContraindication]->(dis:Disorder)\nRETURN d.primaryDomainId AS drugId, d.displayName AS drugDisplayName, dis.primaryDomainId AS disId, dis.displayName AS disDisplayName",
  "isCorrect" : true,
  "question" : "List the contraindications for Paroxetine.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer**  \nHereditary breast carcinoma is linked to a broad set of genes, most notably the classic BRCA1 and BRCA2.  Other frequently implicated genes include PALB2, CHEK2, ATM, BRIP1, PTEN, CDH1, TP53, PPM1D, and the RAD51/RAD54 family of DNA‑repair proteins, among several additional genes in the list.\n\n**Evidence**  \n- **BRCA1** (entrez.672) – hereditary breast‑carcinoma gene  \n- **BRCA2** (entrez.675) – hereditary breast‑carcinoma gene  \n- **PALB2** (entrez.79728) – hereditary breast‑carcinoma gene  \n- **CHEK2** (entrez.11200) – hereditary breast‑carcinoma gene  \n- **ATM** (entrez.472) – hereditary breast‑carcinoma gene  \n- **BRIP1** (entrez.83990) – hereditary breast‑carcinoma gene  \n- **PTEN** (entrez.5728) – hereditary breast‑carcinoma gene  \n- **CDH1** (entrez.999) – hereditary breast‑carcinoma gene  \n- **TP53** (entrez.7157) – hereditary breast‑carcinoma gene  \n- **PPM1D** (entrez.8493) – hereditary breast‑carcinoma gene  \n- **RAD51** (entrez.5888) – hereditary breast‑carcinoma gene  \n- **RAD54L** (entrez.8438) – hereditary breast‑carcinoma gene  \n\n**Details**  \n\n| Gene Name | Gene ID |\n|-----------|---------|\n| BLM | entrez.641 |\n| FANCM | entrez.57697 |\n| TMEM132E | entrez.124842 |\n| PTEN | entrez.5728 |\n| C11orf65 | entrez.160140 |\n| RET | entrez.5979 |\n| ZNF462 | entrez.58499 |\n| AKT1 | entrez.207 |\n| TP53 | entrez.7157 |\n| FBXO11 | entrez.80204 |\n| BRIP1 | entrez.83990 |\n| CDC73 | entrez.79577 |\n| KRAS | entrez.3845 |\n| LRRC41 | entrez.10489 |\n| ABCC1 | entrez.4363 |\n| RAD51 | entrez.5888 |\n| NQO2 | entrez.4835 |\n| KLLN | entrez.100144748 |\n| PALB2 | entrez.79728 |\n| CHEK2 | entrez.11200 |\n| RAD50 | entrez.10111 |\n| PPM1D | entrez.8493 |\n| RAD54L | entrez.8438 |\n| RAD51D | entrez.5892 |\n| MSH2 | entrez.4436 |\n| NBN | entrez.4683 |\n| MLH1 | entrez.4292 |\n| EPCAM | entrez.4072 |\n| MUTYH | entrez.4595 |\n| MSH6 | entrez.2956 |\n| BRCA2 | entrez.675 |\n| BRCA1 | entrez.672 |\n| ATM | entrez.472 |\n| BARD1 | entrez.580 |\n| CDH1 | entrez.999 |\n| SLC67A1 | entrez.5002 |\n| PIK3CA | entrez.5290 |",
  "context" : "[{\"geneId\": \"entrez.641\", \"geneName\": \"BLM\"}, {\"geneId\": \"entrez.57697\", \"geneName\": \"FANCM\"}, {\"geneId\": \"entrez.124842\", \"geneName\": \"TMEM132E\"}, {\"geneId\": \"entrez.5728\", \"geneName\": \"PTEN\"}, {\"geneId\": \"entrez.160140\", \"geneName\": \"C11orf65\"}, {\"geneId\": \"entrez.5979\", \"geneName\": \"RET\"}, {\"geneId\": \"entrez.58499\", \"geneName\": \"ZNF462\"}, {\"geneId\": \"entrez.207\", \"geneName\": \"AKT1\"}, {\"geneId\": \"entrez.7157\", \"geneName\": \"TP53\"}, {\"geneId\": \"entrez.80204\", \"geneName\": \"FBXO11\"}, {\"geneId\": \"entrez.83990\", \"geneName\": \"BRIP1\"}, {\"geneId\": \"entrez.79577\", \"geneName\": \"CDC73\"}, {\"geneId\": \"entrez.3845\", \"geneName\": \"KRAS\"}, {\"geneId\": \"entrez.10489\", \"geneName\": \"LRRC41\"}, {\"geneId\": \"entrez.4363\", \"geneName\": \"ABCC1\"}, {\"geneId\": \"entrez.5888\", \"geneName\": \"RAD51\"}, {\"geneId\": \"entrez.4835\", \"geneName\": \"NQO2\"}, {\"geneId\": \"entrez.100144748\", \"geneName\": \"KLLN\"}, {\"geneId\": \"entrez.79728\", \"geneName\": \"PALB2\"}, {\"geneId\": \"entrez.11200\", \"geneName\": \"CHEK2\"}, {\"geneId\": \"entrez.10111\", \"geneName\": \"RAD50\"}, {\"geneId\": \"entrez.8493\", \"geneName\": \"PPM1D\"}, {\"geneId\": \"entrez.8438\", \"geneName\": \"RAD54L\"}, {\"geneId\": \"entrez.5892\", \"geneName\": \"RAD51D\"}, {\"geneId\": \"entrez.4436\", \"geneName\": \"MSH2\"}, {\"geneId\": \"entrez.4683\", \"geneName\": \"NBN\"}, {\"geneId\": \"entrez.4292\", \"geneName\": \"MLH1\"}, {\"geneId\": \"entrez.4072\", \"geneName\": \"EPCAM\"}, {\"geneId\": \"entrez.4595\", \"geneName\": \"MUTYH\"}, {\"geneId\": \"entrez.2956\", \"geneName\": \"MSH6\"}, {\"geneId\": \"entrez.675\", \"geneName\": \"BRCA2\"}, {\"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"geneId\": \"entrez.472\", \"geneName\": \"ATM\"}, {\"geneId\": \"entrez.580\", \"geneName\": \"BARD1\"}, {\"geneId\": \"entrez.999\", \"geneName\": \"CDH1\"}, {\"geneId\": \"entrez.5002\", \"geneName\": \"SLC67A1\"}, {\"geneId\": \"entrez.5290\", \"geneName\": \"PIK3CA\"}]",
  "cypher" : "MATCH (dis:Disorder {primaryDomainId:'mondo.0016419'})\nMATCH (g:Gene)-[r:GeneAssociatedWithDisorder]->(dis)\nWHERE r.scoreOpenTargets IS NULL OR r.scoreOpenTargets > 0.3\nRETURN g.primaryDomainId AS geneId, g.displayName AS geneName",
  "isCorrect" : false,
  "question" : "What genes are associated with hereditary breast carcinoma?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe primary domain ID for cystic fibrosis is **MONDO:0009061**.  \n\n**Evidence:**  \n• *cystic fibrosis* (mondo.0009061) – primary domain ID.",
  "context" : "[{\"disorderId\": \"mondo.0009061\", \"disorderName\": \"cystic fibrosis\"}]",
  "cypher" : "MATCH (dis:Disorder)\nWHERE toLower(dis.displayName) = toLower('cystic fibrosis')\nRETURN dis.primaryDomainId AS disorderId, dis.displayName AS disorderName;",
  "isCorrect" : false,
  "question" : "What is the primary domain ID for cystic fibrosis?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe disorder information for Li‑Fraumeni syndrome is sourced from the MONDO database (MONDO:0018875).\n\n**Evidence:**\n- Li‑Fraumeni syndrome (MONDO:0018875) – data source: *mondo*\n\n**Details:**\n\n| Disorder ID | Disorder Name          | Data Sources |\n|-------------|------------------------|--------------|\n| mondo.0018875 | Li‑Fraumeni syndrome | mondo         |",
  "context" : "[{\"disorderId\": \"mondo.0018875\", \"disorderName\": \"Li-Fraumeni syndrome\", \"dataSources\": [\"mondo\"]}]",
  "cypher" : "MATCH (dis:Disorder)\nWHERE toLower(dis.displayName) = toLower('Li-Fraumeni syndrome')\nRETURN dis.primaryDomainId AS disorderId, dis.displayName AS disorderName, dis.dataSources AS dataSources",
  "isCorrect" : true,
  "question" : "What are the data sources for the disorder information on Li-Fraumeni syndrome?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe ICD‑10 codes associated with Wilson disease are **E83.0** and **E83**.\n\n**Evidence:**  \n- Wilson disease (mondo.0010200) – ICD‑10 codes E83.0, E83.",
  "context" : "[{\"disorderId\": \"mondo.0010200\", \"disorderName\": \"Wilson disease\", \"icd10Codes\": [\"E83.0\", \"E83\"]}]",
  "cypher" : "MATCH (dis:Disorder)\nWHERE toLower(dis.displayName) = toLower('Wilson disease')\nRETURN dis.primaryDomainId AS disorderId, dis.displayName AS disorderName, dis.icd10 AS icd10Codes",
  "isCorrect" : true,
  "question" : "What are the ICD10 codes associated with Wilson disease?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nAtaxia telangiectasia is linked to a range of phenotypes, each with a specific clinical description (when available). The key phenotypes and their descriptions are:\n\n| Phenotype | ID | Clinical description |\n|-----------|----|----------------------|\n| Telangiectasia of the skin | hpo.0100585 | Presence of small, permanently dilated blood vessels near the surface of the skin, visible as small focal red lesions. |\n| Mucosal telangiectasiae | hpo.0100579 | Telangiectasia of the mucous membranes lining cavities exposed to the external environment and internal organs. |\n| Cognitive impairment | hpo.0100543 | Abnormal cognition characterized by deficits in thinking, reasoning, or remembering. |\n| Abnormality of movement | hpo.0100022 | An abnormality of movement with a neurological basis characterized by changes in coordination and speed of voluntary movements. |\n| Aplasia/Hypoplasia of the thymus | hpo.0010515 | Absence or underdevelopment of the thymus. |\n| Aplasia/Hypoplasia of the skin | hpo.0008065 | *No clinical description available.* |\n| Multiple café‑au‑lait spots | hpo.0007565 | Presence of six or more café‑au‑lait spots. |\n| Prematurely aged appearance | hpo.0007495 | *No clinical description available.* |\n| Type II diabetes mellitus | hpo.0005978 | Type of diabetes mellitus initially characterized by insulin resistance and hyperinsulinemia, later by glucose intolerance and hyperglycemia. |\n| Hypopigmentation of hair | hpo.0005599 | *No clinical description available.* |\n| Cellular immunodeficiency | hpo.0005374 | Immunodeficiency characterized by defective cell‑mediated or humoral immunity. |\n| Decreased circulating immunoglobulin concentration | hpo.0004313 | An abnormally decreased level of immunoglobulin in blood. |\n| Abnormality of chromosome stability | hpo.0003220 | Chromosomal aberration characterized by reduced resistance of chromosomes to change or deterioration. |\n| Skeletal muscle atrophy | hpo.0003202 | Presence of skeletal muscular atrophy (amyotrophy). |\n| Elevated circulating hepatic transaminase concentration | hpo.0002910 | Elevations of SGOT and SGPT in serum, released into the bloodstream as a result of liver or heart cell damage. |\n\n**Evidence:**\n- Telangiectasia of the skin (hpo.0100585)\n- Mucosal telangiectasiae (hpo.0100579)\n- Cognitive impairment (hpo.0100543)\n- Abnormality of movement (hpo.0100022)\n- Aplasia/Hypoplasia of the thymus (hpo.0010515)\n- Aplasia/Hypoplasia of the skin (hpo.0008065)\n- Multiple café‑au‑lait spots (hpo.0007565)\n- Prematurely aged appearance (hpo.0007495)\n- Type II diabetes mellitus (hpo.0005978)\n- Hypopigmentation of hair (hpo.0005599)\n- Cellular immunodeficiency (hpo.0005374)\n- Decreased circulating immunoglobulin concentration (hpo.0004313)\n- Abnormality of chromosome stability (hpo.0003220)\n- Skeletal muscle atrophy (hpo.0003202)\n- Elevated circulating hepatic transaminase concentration (hpo.0002910)",
  "context" : "[{\"phenotypeId\": \"hpo.0100585\", \"phenotypeName\": \"Telangiectasia of the skin\", \"clinicalDescription\": \"Presence of small, permanently dilated blood vessels near the surface of the skin, visible as small focal red lesions.\"}, {\"phenotypeId\": \"hpo.0100579\", \"phenotypeName\": \"Mucosal telangiectasiae\", \"clinicalDescription\": \"Telangiectasia of the mucosa, the mucous membranes which are involved in absorption and secretion that line cavities that are exposed to the external environment and internal organs.\"}, {\"phenotypeId\": \"hpo.0100543\", \"phenotypeName\": \"Cognitive impairment\", \"clinicalDescription\": \"Abnormal cognition is characterized by deficits in thinking, reasoning, or remembering.\"}, {\"phenotypeId\": \"hpo.0100022\", \"phenotypeName\": \"Abnormality of movement\", \"clinicalDescription\": \"An abnormality of movement with a neurological basis characterized by changes in coordination and speed of voluntary movements.\"}, {\"phenotypeId\": \"hpo.0010515\", \"phenotypeName\": \"Aplasia/Hypoplasia of the thymus\", \"clinicalDescription\": \"Absence or underdevelopment of the thymus.\"}, {\"phenotypeId\": \"hpo.0008065\", \"phenotypeName\": \"Aplasia/Hypoplasia of the skin\", \"clinicalDescription\": null}, {\"phenotypeId\": \"hpo.0007565\", \"phenotypeName\": \"Multiple cafe-au-lait spots\", \"clinicalDescription\": \"The presence of six or more cafe-au-lait spots.\"}, {\"phenotypeId\": \"hpo.0007495\", \"phenotypeName\": \"Prematurely aged appearance\", \"clinicalDescription\": null}, {\"phenotypeId\": \"hpo.0005978\", \"phenotypeName\": \"Type II diabetes mellitus\", \"clinicalDescription\": \"A type of diabetes mellitus initially characterized by insulin resistance and hyperinsulinemia and subsequently by glucose interolerance and hyperglycemia.\"}, {\"phenotypeId\": \"hpo.0005599\", \"phenotypeName\": \"Hypopigmentation of hair\", \"clinicalDescription\": null}, {\"phenotypeId\": \"hpo.0005374\", \"phenotypeName\": \"Cellular immunodeficiency\", \"clinicalDescription\": \"An immunodeficiency characterized by defective cell-mediated immunity or humoral immunity.\"}, {\"phenotypeId\": \"hpo.0004313\", \"phenotypeName\": \"Decreased circulating immunoglobulin concentration\", \"clinicalDescription\": \"An abnormally decreased level of immunoglobulin in blood.\"}, {\"phenotypeId\": \"hpo.0003220\", \"phenotypeName\": \"Abnormality of chromosome stability\", \"clinicalDescription\": \"A type of chromosomal aberration characterized by reduced resistance of chromosomes to change or deterioration.\"}, {\"phenotypeId\": \"hpo.0003202\", \"phenotypeName\": \"Skeletal muscle atrophy\", \"clinicalDescription\": \"The presence of skeletal muscular atrophy (which is also known as amyotrophy).\"}, {\"phenotypeId\": \"hpo.0002910\", \"phenotypeName\": \"Elevated circulating hepatic transaminase concentration\", \"clinicalDescription\": \"Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result... (truncated)",
  "cypher" : "MATCH (dis:Disorder {primaryDomainId:'mondo.0008840'})-[:DisorderHasPhenotype]->(ph:Phenotype)\nRETURN ph.primaryDomainId AS phenotypeId, ph.displayName AS phenotypeName, ph.description AS clinicalDescription;",
  "isCorrect" : true,
  "question" : "What are the clinical descriptions for the phenotypes associated with ataxia telangiectasia?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(dis:Disorder {primaryDomainId:'mondo.0004379'})\nWHERE v.variantType = 'SNP' AND v.chromosome = 'X'\nRETURN v.primaryDomainId AS variantId, v.displayName AS variantName, v.variantType, v.chromosome, dis.primaryDomainId AS disorderId, dis.displayName AS disorderName;",
  "isCorrect" : false,
  "question" : "Find all genomic variants of type SNP located on chromosome X that are associated with breast cancer.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer**  \nThe knowledge graph contains a number of cystic‑fibrosis‑associated variants on chromosome 7 with the reference and alternative allele sequences shown below.\n\n**Evidence**  \n- *clinvar.634910* – reference: long A‑string; alternative: **T**  \n- *clinvar.818099* – reference: **C**; alternative: **G**  \n- *clinvar.558519* – reference: **T**; alternative: **C**  \n- *clinvar.557329* – reference: **CATT**; alternative: **C**  \n- *clinvar.439085* – reference: **A**; alternative: **G**  \n- *clinvar.439059* – reference: **G**; alternative: **A**  \n- *clinvar.189027* – reference: **A**; alternative: **G**  \n- *clinvar.242535* – reference: **GTT**; alternative: **G** (listed multiple times)  \n- *clinvar.161188* – reference: **G**; alternative: **GTT**  \n- *clinvar.53998* – reference: long TAGCT… sequence; alternative: **T**  \n- *clinvar.53778* – reference: **A**; alternative: **G** (listed twice)  \n- *clinvar.53672* – reference: **G**; alternative: **C** (listed twice)  \n- *clinvar.53638* – reference: **…** (data truncated)  \n\n**Details**\n\n| Variant ID | Reference Sequence | Alternative Sequence |\n|------------|--------------------|----------------------|\n| clinvar.634910 | TACAGTTGTTATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATGACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGTTAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTACATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAATGACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAGGACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAAGGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGGGAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATATTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCAGTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCCAAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAATGTTTTCTATGGAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACA | T |\n| clinvar.818099 | C | G |\n| clinvar.558519 | T | C |\n| clinvar.557329 | CATT | C |\n| clinvar.439085 | A | G |\n| clinvar.439059 | G | A |\n| clinvar.189027 | A | G |\n| clinvar.242535 | GTT | G |\n| clinvar.161188 | G | GTT |\n| clinvar.53998 | TAGCTGGACCAGACCAATTTTGAGGAAAGGATACAGACAGCGCCTGGAATTGTCAGACATATACCAAATCCCTTCTGTTGATTCTGCTGACAATCTATCTGAAAAATTGGAA | T |\n| clinvar.53778 | A | G |\n| clinvar.53672 | G | C |\n| clinvar.53638 | … | … *(data truncated)* |\n\n*(All variants are linked to cystic fibrosis and located on chromosome 7 in the graph.)*",
  "context" : "[{\"variantId\": \"clinvar.634910\", \"v.referenceSequence\": \"TACAGTTGTTATTAATTGTGATTGGAGCTATAGCAGTTGTCGCAGTTTTACAACCCTACATCTTTGTTGCAACAGTGCCAGTGATAGTGGCTTTTATTATGTTGAGAGCATATTTCCTCCAAACCTCACAGCAACTCAAACAACTGGAATCTGAAGGTATGACAGTGAATGTGCGATACTCATCTTGTAAAAAAGCTATAAGAGCTATTTGAGATTCTTTATTGTTAATCTACTTAAAAAAAATTCTGCTTTTAAACTTTTACATCATATAACAATAATTTTTTTCTACATGCATGTGTATATAAAAGGAAACTATATTACAAAGTACACATGGATTTTTTTTCTTAATTAATGACCATGTGACTTCATTTTGGTTTTAAAATAGGTATATAGAATCTTACCACAGTTGGTGTACAGGACATTCATTTATAATAAACTTATATCAGTCAAATTAAACAAGGATAGTGCTGCTATTACTAAAGGTTTCTCTGGGTTCCCAAATGATACTTGACCAAATTTGTCCCTTTGGCTTGTTGTCTTCAGACACCCTTTCTTCATGTGTTGGAGCTGCCATTTCGTGTGCCCCCAAACTCTACTTGAGCTGTTAGGGAATCACATTTTGCAGTGACAGCCTTAGTGTGGGTGCATTTTCAGGCAATACTTTTTCAGTATATTTCTGCTTTGTAGATTATTAGCTAAATCAAGTCACATAAACTTCCTTAATTTAGATACTTGAAAAAATTGTCTTAAAAGAAAATTTTTTTAGTAAGAATTAATTTAGAATTAGCCAGAAAACTCCCAGTGGTAGCCAAGAAAGAGGAATAAATATTGGTGGTAATTTTTTAAGTTCCCATCTCTGGTAGCCAAGTAAAAAAAGAGGGTAACTCATTAATAAAATAACAAATCATATCTATTCAAAGAATGGCACCAGTGTGAAAAAAAGCTTTTTAACCAATGACATTTGTGATATGATTATTCTAATTTAGTCTTTTTCAGGTACAAGATATTATGAAATTACATTTTGTGTTTATGTTATTTGCAATGTTTTCTATGGAAATATTTCACAGGCAGGAGTCCAATTTTCACTCATCTTGTTACAAGCTTAAAAGGACTATGGACACTTCGTGCCTTCGGACGGCAGCCTTACTTTGAAACTCTGTTCCACAAAGCTCTGAATTTACATACTGCCAACTGGTTCTTGTACCTGTCAACACTGCGCTGGTTCCAAATGAGAATAGAAATGATTTTTGTCATCTTCTTCATTGCTGTTACCTTCATTTCCATTTTAACA\", \"v.alternativeSequence\": \"T\"}, {\"variantId\": \"clinvar.818099\", \"v.referenceSequence\": \"C\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.558519\", \"v.referenceSequence\": \"T\", \"v.alternativeSequence\": \"C\"}, {\"variantId\": \"clinvar.557329\", \"v.referenceSequence\": \"CATT\", \"v.alternativeSequence\": \"C\"}, {\"variantId\": \"clinvar.439085\", \"v.referenceSequence\": \"A\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.439059\", \"v.referenceSequence\": \"G\", \"v.alternativeSequence\": \"A\"}, {\"variantId\": \"clinvar.189027\", \"v.referenceSequence\": \"A\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.242535\", \"v.referenceSequence\": \"GTT\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.242535\", \"v.referenceSequence\": \"GTT\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.242535\", \"v.referenceSequence\": \"GTT\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.242535\", \"v.referenceSequence\": \"GTT\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.161188\", \"v.referenceSequence\": \"G\", \"v.alternativeSequence\": \"GTT\"}, {\"variantId\": \"clinvar.53998\", \"v.referenceSequence\": \"TAGCTGGACCAGACCAATTTTGAGGAAAGGATACAGACAGCGCCTGGAATTGTCAGACATATACCAAATCCCTTCTGTTGATTCTGCTGACAATCTATCTGAAAAATTGGAA\", \"v.alternativeSequence\": \"T\"}, {\"variantId\": \"clinvar.53778\", \"v.referenceSequence\": \"A\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.53778\", \"v.referenceSequence\": \"A\", \"v.alternativeSequence\": \"G\"}, {\"variantId\": \"clinvar.53672\", \"v.referenceSequence\": \"G\", \"v.alternativeSequence\": \"C\"}, {\"variantId\": \"clinvar.53672\", \"v.referenceSequence\": \"G\", \"v.alternativeSequence\": \"C\"}, {\"variantId\": \"clinvar.53638\", \"v.reference... (truncated)",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(dis:Disorder)\nWHERE v.chromosome = '7'\n  AND (dis.primaryDomainId IN ['mondo.1010043', 'mondo.1010544', 'mondo.1010543', 'mondo.1010545', 'mondo.0005219'] \n       OR toLower(dis.displayName) CONTAINS 'cystic fibrosis')\nRETURN v.primaryDomainId AS variantId, v.referenceSequence, v.alternativeSequence;",
  "isCorrect" : false,
  "question" : "Return the reference and alternative sequences for all variants associated with cystic fibrosis located on chromosome 7.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nGenomic variants linked to Parkinson’s disease include three distinct variant types: Single Nucleotide Variant, Indel, and Deletion.  \n\n**Evidence:**  \n- Single Nucleotide Variant – variant type observed in Parkinson’s disease variants  \n- Indel – variant type observed in Parkinson’s disease variants  \n- Deletion – variant type observed in Parkinson’s disease variants",
  "context" : "[{\"variantType\": \"Single Nucleotide Variant\"}, {\"variantType\": \"Indel\"}, {\"variantType\": \"Deletion\"}]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(dis:Disorder {primaryDomainId:'mondo.0005180'})\nRETURN DISTINCT v.variantType AS variantType",
  "isCorrect" : true,
  "question" : "What are the different variant types observed in genomic variants associated with Parkinson's disease?",
  "attempt" : 1,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(d1:Disorder {primaryDomainId:'mondo.0005147'})\nMATCH (v)-[:VariantAssociatedWithDisorder]->(d2:Disorder {primaryDomainId:'mondo.0005148'})\nRETURN DISTINCT v.primaryDomainId AS variantId,\n              v.displayName AS variantName,\n              v.variantType AS variantType,\n              v.chromosome AS chromosome,\n              v.position AS position,\n              v.alternativeSequence AS altSeq,\n              v.referenceSequence AS refSeq;",
  "isCorrect" : false,
  "question" : "Are there any common genomic variants associated with both type 1 and type 2 diabetes?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAffectsGene]->(g:Gene {primaryDomainId:'entrez.672'})\nWHERE v.variantType = 'SNV'\nRETURN v.primaryDomainId AS variantId, v.displayName AS variantName;",
  "isCorrect" : true,
  "question" : "Find all genomic variants of type 'SNV' located within the BRCA1 gene.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the scope of the query, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant {chromosome:'X', position:12345, alternativeSequence:'A'})-[:VariantAffectsGene]->(g:Gene)\nRETURN g.primaryDomainId AS geneId, g.displayName AS geneName",
  "isCorrect" : true,
  "question" : "List the genes affected by variants with an alternative sequence of 'A' at position 12345 on chromosome X.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for the variant, broaden the chromosome or position range, or relax any filtering criteria that might have excluded relevant data.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(dis:Disorder)\nWHERE v.position = 78901 AND (v.chromosome = '2' OR v.chromosome = 'chr2')\n  AND toLower(dis.displayName) = toLower('melanoma')\nRETURN v.referenceSequence AS referenceSequence,\n       v.primaryDomainId AS variantId,\n       v.displayName AS variantName,\n       dis.primaryDomainId AS disorderId,\n       dis.displayName AS disorderName;",
  "isCorrect" : true,
  "question" : "What is the reference sequence for the variant at position 78901 on chromosome 2 associated with melanoma?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe graph contains several ClinVar variants that are reported to cause *Intellectual disability*.  \n* **Usher syndrome type 1** (MONDO 0010168) is associated with the variant **clinvar.228282**.  \n* **Hyperlysinemia** (MONDO 0009388) is linked to many ClinVar variants, including **clinvar.4072352, 3764618, 2957962, 2438707, 1516672, 1334629, 1322091, 1220244, 1098670, 1048522, 1048521, 973464, 973452, 377290, 252652**.  \nNo variants linked to the *Seizure* phenotype (HPO 0001249) are present in this result set.\n\n**Evidence**  \n- clinvar.228282 – associated with Usher syndrome type 1 (MONDO 0010168) – Intellectual disability (HPO 0001249)  \n- clinvar.4072352 – associated with hyperlysinemia (MONDO 0009388) – Intellectual disability  \n- clinvar.3764618 – same as above  \n- clinvar.2957962 – same as above  \n- clinvar.2438707 – same as above  \n- clinvar.1516672 – same as above  \n- clinvar.1334629 – same as above  \n- clinvar.1322091 – same as above  \n- clinvar.1220244 – same as above  \n- clinvar.1098670 – same as above  \n- clinvar.1048522 – same as above  \n- clinvar.1048521 – same as above  \n- clinvar.973464 – same as above  \n- clinvar.973452 – same as above  \n- clinvar.377290 – same as above  \n- clinvar.252652 – same as above  \n\n**Details**\n\n| Variant ID | Disorder ID | Disorder Name | Phenotype ID | Phenotype Name |\n|------------|-------------|---------------|--------------|----------------|\n| clinvar.228282 | mondo.0010168 | Usher syndrome type 1 | hpo.0001249 | Intellectual disability |\n| clinvar.4072352 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.3764618 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.2957962 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.2438707 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1516672 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1334629 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1322091 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1220244 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1098670 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1048522 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.1048521 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.973464 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.973452 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.377290 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |\n| clinvar.252652 | mondo.0009388 | hyperlysinemia | hpo.0001249 | Intellectual disability |",
  "context" : "[{\"variantId\": \"clinvar.228282\", \"variantName\": null, \"disorderId\": \"mondo.0010168\", \"disorderName\": \"Usher syndrome type 1\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.4072352\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.3764618\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.2957962\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.2438707\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1516672\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1334629\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1322091\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1220244\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1098670\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1048522\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.1048521\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.973464\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.973452\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.377290\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"disorderName\": \"hyperlysinemia\", \"phenotypeId\": \"hpo.0001249\", \"phenotypeName\": \"Intellectual disability\"}, {\"variantId\": \"clinvar.252652\", \"variantName\": null, \"disorderId\": \"mondo.0009388\", \"d... (truncated)",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(dis:Disorder)-[:DisorderHasPhenotype]->(ph:Phenotype)\nWHERE ph.primaryDomainId IN ['hpo.0001250','hpo.0001249']\nRETURN DISTINCT v.primaryDomainId AS variantId, v.displayName AS variantName,\n       dis.primaryDomainId AS disorderId, dis.displayName AS disorderName,\n       ph.primaryDomainId AS phenotypeId, ph.displayName AS phenotypeName;",
  "isCorrect" : true,
  "question" : "What are the genetic variants associated with phenotypes like 'Seizure' and 'Intellectual disability'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer:  \nIn children whose primary feature is short stature, the graph shows a cluster of co‑occurring phenotypes that span growth, endocrine, skeletal, craniofacial and dental domains.  Common overlapping traits include markers of impaired growth (intrauterine growth retardation, small for gestational age), metabolic/endocrine abnormalities (diabetes mellitus, glucose intolerance, weight loss, poor appetite), skeletal dysmorphisms (brachydactyly, short palm, enlarged epiphyses), craniofacial dysmorphism (hypertelorism, frontal bossing, wide nasal bridge, underdeveloped nasal alae), and dental anomalies (microdontia, abnormal enamel morphology, abnormal dentition).  \n\nEvidence:  \n• Severe short stature (hpo.0003510) – phenotype of interest  \n• Intrauterine growth retardation (hpo.0001511) – growth delay  \n• Small for gestational age (hpo.0001518) – prenatal growth restriction  \n• Weight loss (hpo.0001824) – metabolic impact  \n• Glucose intolerance (hpo.0001952) – endocrine comorbidity  \n• Diabetes mellitus (hpo.0000819) – endocrine comorbidity  \n• Poor appetite (hpo.0004396) – feeding difficulty  \n• Brachydactyly (hpo.0001156) – skeletal anomaly  \n• Short palm (hpo.0004279) – skeletal anomaly  \n• Enlarged epiphyses (hpo.0010580) – skeletal anomaly  \n• Hypertelorism (hpo.0000316) – craniofacial feature  \n• Frontal bossing (hpo.0002007) – craniofacial feature  \n• Wide nasal bridge (hpo.0000431) – craniofacial feature  \n• Underdeveloped nasal alae (hpo.0000430) – craniofacial feature  \n• Microdontia (hpo.0000691) – dental feature  \n• Abnormal enamel morphology (hpo.0000682) – dental feature  \n• Abnormal dentition (hpo.0000164) – dental feature  \n\nDetails (selected key phenotypes):  \n\n| Phenotype ID | Phenotype Name |\n|--------------|----------------|\n| hpo.0003510 | Severe short stature |\n| hpo.0001511 | Intrauterine growth retardation |\n| hpo.0001518 | Small for gestational age |\n| hpo.0001824 | Weight loss |\n| hpo.0001952 | Glucose intolerance |\n| hpo.0000819 | Diabetes mellitus |\n| hpo.0004396 | Poor appetite |\n| hpo.0001156 | Brachydactyly |\n| hpo.0004279 | Short palm |\n| hpo.0010580 | Enlarged epiphyses |\n| hpo.0000316 | Hypertelorism |\n| hpo.0002007 | Frontal bossing |\n| hpo.0000431 | Wide nasal bridge |\n| hpo.0000430 | Underdeveloped nasal alae |\n| hpo.0000691 | Microdontia |\n| hpo.0000682 | Abnormal enamel morphology |\n| hpo.0000164 | Abnormal dentition |",
  "context" : "[{\"phenotypeId\": \"hpo.0010668\", \"phenotypeName\": \"Abnormal zygomatic bone morphology\"}, {\"phenotypeId\": \"hpo.0007957\", \"phenotypeName\": \"Corneal opacity\"}, {\"phenotypeId\": \"hpo.0004279\", \"phenotypeName\": \"Short palm\"}, {\"phenotypeId\": \"hpo.0001156\", \"phenotypeName\": \"Brachydactyly\"}, {\"phenotypeId\": \"hpo.0000627\", \"phenotypeName\": \"Posterior embryotoxon\"}, {\"phenotypeId\": \"hpo.0000593\", \"phenotypeName\": \"Abnormal anterior chamber morphology\"}, {\"phenotypeId\": \"hpo.0000336\", \"phenotypeName\": \"Prominent supraorbital ridges\"}, {\"phenotypeId\": \"hpo.0000316\", \"phenotypeName\": \"Hypertelorism\"}, {\"phenotypeId\": \"hpo.0000277\", \"phenotypeName\": \"Abnormal mandible morphology\"}, {\"phenotypeId\": \"hpo.0000272\", \"phenotypeName\": \"Malar flattening\"}, {\"phenotypeId\": \"hpo.0008070\", \"phenotypeName\": \"Sparse hair\"}, {\"phenotypeId\": \"hpo.0007392\", \"phenotypeName\": \"Excessive wrinkled skin\"}, {\"phenotypeId\": \"hpo.0004396\", \"phenotypeName\": \"Poor appetite\"}, {\"phenotypeId\": \"hpo.0002167\", \"phenotypeName\": \"Abnormal speech pattern\"}, {\"phenotypeId\": \"hpo.0001824\", \"phenotypeName\": \"Weight loss\"}, {\"phenotypeId\": \"hpo.0001596\", \"phenotypeName\": \"Alopecia\"}, {\"phenotypeId\": \"hpo.0000819\", \"phenotypeName\": \"Diabetes mellitus\"}, {\"phenotypeId\": \"hpo.0000691\", \"phenotypeName\": \"Microdontia\"}, {\"phenotypeId\": \"hpo.0000682\", \"phenotypeName\": \"Abnormal dental enamel morphology\"}, {\"phenotypeId\": \"hpo.0000615\", \"phenotypeName\": \"Abnormal pupil morphology\"}, {\"phenotypeId\": \"hpo.0000271\", \"phenotypeName\": \"Abnormality of the face\"}, {\"phenotypeId\": \"hpo.0000164\", \"phenotypeName\": \"Abnormality of the dentition\"}, {\"phenotypeId\": \"hpo.0007676\", \"phenotypeName\": \"Hypoplasia of the iris\"}, {\"phenotypeId\": \"hpo.0003510\", \"phenotypeName\": \"Severe short stature\"}, {\"phenotypeId\": \"hpo.0001952\", \"phenotypeName\": \"Glucose intolerance\"}, {\"phenotypeId\": \"hpo.0000545\", \"phenotypeName\": \"Myopia\"}, {\"phenotypeId\": \"hpo.0000347\", \"phenotypeName\": \"Micrognathia\"}, {\"phenotypeId\": \"hpo.0000501\", \"phenotypeName\": \"Glaucoma\"}, {\"phenotypeId\": \"hpo.0001511\", \"phenotypeName\": \"Intrauterine growth retardation\"}, {\"phenotypeId\": \"hpo.0002007\", \"phenotypeName\": \"Frontal bossing\"}, {\"phenotypeId\": \"hpo.0000668\", \"phenotypeName\": \"Hypodontia\"}, {\"phenotypeId\": \"hpo.0000506\", \"phenotypeName\": \"Telecanthus\"}, {\"phenotypeId\": \"hpo.0001518\", \"phenotypeName\": \"Small for gestational age\"}, {\"phenotypeId\": \"hpo.0100678\", \"phenotypeName\": \"Premature skin wrinkling\"}, {\"phenotypeId\": \"hpo.0010580\", \"phenotypeName\": \"Enlarged epiphyses\"}, {\"phenotypeId\": \"hpo.0003100\", \"phenotypeName\": \"Slender long bone\"}, {\"phenotypeId\": \"hpo.0000430\", \"phenotypeName\": \"Underdeveloped nasal alae\"}, {\"phenotypeId\": \"hpo.0000431\", \"phenotypeName\": \"Wide nasal bridge\"}, {\"phenotypeId\": \"hpo.0000750\", \"phenotypeName\": \"Delayed speech and language development\"}, {\"phenotypeId\": \"hpo.0000138\", \"phenotypeName\": \"Ovarian cyst\"}, {\"phenotypeId\": \"hpo.0002714\", \"phenotypeName\": \"Downturned corners of mouth\"}, {\"phenotypeId\": \"hpo.003008... (truncated)",
  "cypher" : "MATCH (dis:Disorder)-[:DisorderHasPhenotype]->(ph:Phenotype)\nWHERE dis.primaryDomainId IN ['mondo.0010026','mondo.0014551','mondo.0014686','mondo.0010025','mondo.0014403']\nRETURN DISTINCT ph.primaryDomainId AS phenotypeId, ph.displayName AS phenotypeName;",
  "isCorrect" : false,
  "question" : "What are the common comorbidities or overlapping phenotypes observed with 'Short stature' in children?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (dis:Disorder)-[:DisorderHasPhenotype]->(phInf:Phenotype),\n      (dis)-[:DisorderHasPhenotype]->(phHet:Phenotype)\nWHERE phInf.primaryDomainId IN ['hpo.0032809','hpo.0032807','hpo.0032808','hpo.0032811','hpo.0033259']\n  AND toLower(phHet.displayName) = toLower('Hypertelorism')\nRETURN DISTINCT dis.primaryDomainId AS disorderId, dis.displayName AS disorderName;",
  "isCorrect" : true,
  "question" : "What are the differential diagnoses for a patient presenting with 'Infantile onset' seizures and 'Hypertelorism'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No prevalence data for Micrognathia in patients with Failure to thrive and Delayed speech and language development was found in the graph.  \n\nEvidence:  \n- prevalence () – null  \n\nNext steps: Try alternative names or synonyms for the conditions, broaden the scope of the query, or relax any applied filters.",
  "context" : "[{\"prevalence\": null}]",
  "cypher" : "RETURN null AS prevalence;",
  "isCorrect" : true,
  "question" : "What is the prevalence of 'Micrognathia' in patients with 'Failure to thrive' and 'Delayed speech and language development'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (d:Disorder)-[:DisorderHasPhenotype]->(feeding:Phenotype {primaryDomainId:'hpo.0011968'})\nWHERE d.primaryDomainId IN ['mondo.0016593','mondo.0100308','mondo.0100309','mondo.0100311','mondo.0016227']\nMATCH (d)-[:DisorderHasPhenotype]->(outcome:Phenotype)\nWHERE outcome.primaryDomainId IN ['hpo.0011343','hpo.0012736','hpo.0001263','hpo.0011342','hpo.0011344']\nRETURN DISTINCT outcome.primaryDomainId AS outcomeId, outcome.displayName AS outcomeName;",
  "isCorrect" : true,
  "question" : "What are the long-term developmental outcomes for individuals with 'Ataxia' and 'Feeding difficulties'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nYes. The graph shows that the “Immunoglobulins” gene‑expression signature is linked to a wide range of disorders.  Each row in the result set represents a distinct disorder that has been annotated as related to this signature.  \n\n**Evidence:**  \n- *Immunoglobulins* signature – associated with listed disorders  \n\n**Details**\n\n| Disorder ID | Disorder Name |\n|-------------|---------------|\n| mondo.0100096 | COVID‑19 |\n| mondo.0005485 | psychotic disorder |\n| mondo.0006592 | parapsoriasis |\n| mondo.0005559 | neurodegenerative disease |\n| mondo.0002491 | substance abuse |\n| mondo.0002009 | major depressive disorder |\n| mondo.0005258 | autism spectrum disorder |\n| mondo.0008114 | obsessive‑compulsive disorder |\n| mondo.0005379 | neurotic disorder |\n| mondo.0007743 | attention deficit‑hyperactivity disorder |\n| mondo.0008383 | rheumatoid arthritis |\n| mondo.0004994 | cardiomyopathy |\n| mondo.0005351 | anorexia nervosa |\n| mondo.0004985 | bipolar disorder |\n| mondo.0005180 | Parkinson disease |\n| mondo.0005090 | schizophrenia |\n| mondo.0000471 | tricuspid valve disorder |\n| mondo.0007661 | Tourette syndrome |\n| mondo.0013600 | insomnia |\n| mondo.0007522 | Ehlers‑Danlos syndrome, classic type |\n| mondo.0020066 | Ehlers‑Danlos syndrome |\n| mondo.0003847 | hereditary disease |\n| mondo.0017329 | familial vesicoureteral reflux |\n| mondo.0008653 | vesicoureteral reflux 1 |\n| mondo.0014422 | vesicoureteral reflux 8 |\n| mondo.0011670 | Ehlers‑Danlos syndrome due to tenascin‑X deficiency |\n| mondo.0005061 | lung adenocarcinoma |\n| mondo.0006336 | ovarian endometrioid adenocarcinoma with squamous differentiation |\n| mondo.0002098 | facial nerve disorder |\n| mondo.0018531 | carcinoma of liver and intrahepatic biliary tract |\n| mondo.0023619 | lentigo maligna melanoma |\n| mondo.0005157 | lymphoid neoplasm |\n| mondo.0005833 | lymphatic system disorder |\n| mondo.0005590 | breast ductal adenocarcinoma |\n| mondo.0004579 | retinoschisis |\n| mondo.0004634 | vein disorder |\n| mondo.0002081 | musculoskeletal system disorder |\n| mondo.0006456 | thymoma |\n| mondo.0005138 | lung carcinoma |\n| mondo.0003120 | *…* |\n\n(Full list continues beyond the truncated portion shown.)",
  "context" : "[{\"disorderId\": \"mondo.0100096\", \"disorderName\": \"COVID-19\"}, {\"disorderId\": \"mondo.0005485\", \"disorderName\": \"psychotic disorder\"}, {\"disorderId\": \"mondo.0006592\", \"disorderName\": \"parapsoriasis\"}, {\"disorderId\": \"mondo.0005559\", \"disorderName\": \"neurodegenerative disease\"}, {\"disorderId\": \"mondo.0002491\", \"disorderName\": \"substance abuse\"}, {\"disorderId\": \"mondo.0002009\", \"disorderName\": \"major depressive disorder\"}, {\"disorderId\": \"mondo.0005258\", \"disorderName\": \"autism spectrum disorder\"}, {\"disorderId\": \"mondo.0008114\", \"disorderName\": \"obsessive-compulsive disorder\"}, {\"disorderId\": \"mondo.0005379\", \"disorderName\": \"neurotic disorder\"}, {\"disorderId\": \"mondo.0007743\", \"disorderName\": \"attention deficit-hyperactivity disorder\"}, {\"disorderId\": \"mondo.0008383\", \"disorderName\": \"rheumatoid arthritis\"}, {\"disorderId\": \"mondo.0004994\", \"disorderName\": \"cardiomyopathy\"}, {\"disorderId\": \"mondo.0005351\", \"disorderName\": \"anorexia nervosa\"}, {\"disorderId\": \"mondo.0004985\", \"disorderName\": \"bipolar disorder\"}, {\"disorderId\": \"mondo.0005180\", \"disorderName\": \"Parkinson disease\"}, {\"disorderId\": \"mondo.0005090\", \"disorderName\": \"schizophrenia\"}, {\"disorderId\": \"mondo.0000471\", \"disorderName\": \"tricuspid valve disorder\"}, {\"disorderId\": \"mondo.0007661\", \"disorderName\": \"Tourette syndrome\"}, {\"disorderId\": \"mondo.0013600\", \"disorderName\": \"insomnia\"}, {\"disorderId\": \"mondo.0007522\", \"disorderName\": \"Ehlers-Danlos syndrome, classic type\"}, {\"disorderId\": \"mondo.0020066\", \"disorderName\": \"Ehlers-Danlos syndrome\"}, {\"disorderId\": \"mondo.0003847\", \"disorderName\": \"hereditary disease\"}, {\"disorderId\": \"mondo.0017329\", \"disorderName\": \"familial vesicoureteral reflux\"}, {\"disorderId\": \"mondo.0008653\", \"disorderName\": \"vesicoureteral reflux 1\"}, {\"disorderId\": \"mondo.0014422\", \"disorderName\": \"vesicoureteral reflux 8\"}, {\"disorderId\": \"mondo.0011670\", \"disorderName\": \"Ehlers-Danlos syndrome due to tenascin-X deficiency\"}, {\"disorderId\": \"mondo.0005061\", \"disorderName\": \"lung adenocarcinoma\"}, {\"disorderId\": \"mondo.0006336\", \"disorderName\": \"ovarian endometrioid adenocarcinoma with squamous differentiation\"}, {\"disorderId\": \"mondo.0002098\", \"disorderName\": \"facial nerve disorder\"}, {\"disorderId\": \"mondo.0018531\", \"disorderName\": \"carcinoma of liver and intrahepatic biliary tract\"}, {\"disorderId\": \"mondo.0023619\", \"disorderName\": \"lentigo maligna melanoma\"}, {\"disorderId\": \"mondo.0005157\", \"disorderName\": \"lymphoid neoplasm\"}, {\"disorderId\": \"mondo.0005833\", \"disorderName\": \"lymphatic system disorder\"}, {\"disorderId\": \"mondo.0005590\", \"disorderName\": \"breast ductal adenocarcinoma\"}, {\"disorderId\": \"mondo.0004579\", \"disorderName\": \"retinoschisis\"}, {\"disorderId\": \"mondo.0004634\", \"disorderName\": \"vein disorder\"}, {\"disorderId\": \"mondo.0002081\", \"disorderName\": \"musculoskeletal system disorder\"}, {\"disorderId\": \"mondo.0006456\", \"disorderName\": \"thymoma\"}, {\"disorderId\": \"mondo.0005138\", \"disorderName\": \"lung carcinoma\"}, {\"disorderId\": \"mondo.0003120\", \"disorderNam... (truncated)",
  "cypher" : "MATCH (s:Signature)\nWHERE toLower(s.displayName) = toLower('Immunoglobulins')\nMATCH (p:Protein)-[:ProteinHasSignature]->(s)\nMATCH (p)-[:ProteinEncodedByGene]->(g:Gene)\nMATCH (g)-[r:GeneAssociatedWithDisorder]->(dis:Disorder)\nWHERE r.scoreOpenTargets IS NULL OR r.scoreOpenTargets > 0.3\nRETURN DISTINCT dis.primaryDomainId AS disorderId, dis.displayName AS disorderName",
  "isCorrect" : false,
  "question" : "Are there any known relationships between the 'Immunoglobulins' signature and specific disorders?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe “Immunoglobulin” signature is sourced from the UniProt database.\n\n**Evidence:**  \n- Immunoglobulin (supfam.SSF48726) – dataSources: uniprot  \n- IMMUNOGLOBULIN (panther.PTHR47633) – dataSources: uniprot",
  "context" : "[{\"signatureId\": \"supfam.SSF48726\", \"signatureName\": \"Immunoglobulin\", \"dataSources\": [\"uniprot\"]}, {\"signatureId\": \"panther.PTHR47633\", \"signatureName\": \"IMMUNOGLOBULIN\", \"dataSources\": [\"uniprot\"]}]",
  "cypher" : "MATCH (s:Signature)\nWHERE toLower(s.displayName) = toLower('Immunoglobulin')\nRETURN s.primaryDomainId AS signatureId, s.displayName AS signatureName, s.dataSources AS dataSources;",
  "isCorrect" : true,
  "question" : "What is the database source for the 'Immunoglobulin' signature?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer:  \nThe evidence shows that the signatures “Ig‑like_dom” and “IG_LIKE” list distinct InterPro entries. None of the InterPro IDs or display names associated with one signature appear in the other, so there is no overlap between them.\n\nEvidence:  \n- Ig‑like_dom (interpro.IPR007110) – Signature  \n- Ig‑like_dom_sf (interpro.IPR036179) – Signature  \n- Ig‑like_domain‑LISCH7 (interpro.IPR051874) – Signature  \n- Immunoglobulin_dom (interpro.IPR013151) – Signature  \n- MPZL2_Ig‑like_dom (interpro.IPR029863) – Signature  \n- IGF2 (interpro.IPR022334) – Signature  \n- Asparaginase/glutaminase_AS2 (interpro.IPR027475) – Signature  \n- Asparaginase/glutaminase‑like (interpro.IPR006034) – Signature  \n- Glyco_trans_2‑like (interpro.IPR001173) – Signature  \n- Galactose_mutarotase‑like (interpro.IPR047215) – Signature  \n\nNo common InterPro ID or display name is present in both lists, indicating no overlap.",
  "context" : "Node Type: signature\nNode Value: Ig-like_dom\nSub Question: overlap with\nNeeds Filter: null\nEnhanced Nodes:\n  - Primary Domain ID: interpro.IPR007110\n    Display Name: Ig-like_dom\n  - Primary Domain ID: interpro.IPR036179\n    Display Name: Ig-like_dom_sf\n  - Primary Domain ID: interpro.IPR051874\n    Display Name: Ig-like_domain-LISCH7\n  - Primary Domain ID: interpro.IPR013151\n    Display Name: Immunoglobulin_dom\n  - Primary Domain ID: interpro.IPR029863\n    Display Name: MPZL2_Ig-like_dom\n\nNode Type: signature\nNode Value: IG_LIKE\nSub Question: overlap with\nNeeds Filter: null\nEnhanced Nodes:\n  - Primary Domain ID: interpro.IPR022334\n    Display Name: IGF2\n  - Primary Domain ID: interpro.IPR027475\n    Display Name: Asparaginase/glutaminase_AS2\n  - Primary Domain ID: interpro.IPR006034\n    Display Name: Asparaginase/glutaminase-like\n  - Primary Domain ID: interpro.IPR001173\n    Display Name: Glyco_trans_2-like\n  - Primary Domain ID: interpro.IPR047215\n    Display Name: Galactose_mutarotase-like\n\n",
  "cypher" : null,
  "isCorrect" : true,
  "question" : "Does the 'Ig-like_dom' signature have any overlap with the 'IG_LIKE' signature?",
  "attempt" : 0,
  "fallback" : true
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (d:Drug)-[:DrugHasTarget]->(p:Protein)-[:ProteinHasSignature]->(s:Signature {primaryDomainId:'pfam.PF14586'})\nRETURN d.primaryDomainId AS drugId, d.displayName AS drugName, p.primaryDomainId AS proteinId, p.displayName AS proteinName, s.primaryDomainId AS signatureId, s.displayName AS signatureName;",
  "isCorrect" : false,
  "question" : "Are there any drugs that target proteins with the 'MHC_I-like_Ag-recog_sf' signature?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nYes.  The graph contains several single‑nucleotide variants (e.g., *clinvar.3061479*, *clinvar.1156873*, *clinvar.1710897*) that lie in chromosome 6 positions near the *HFE* gene.  *HFE* encodes a protein (UniProt B4DV50) that carries the MHC‑I signature “IgC1_MHC_Ib_HLA‑H” (CDD cd21021).\n\n**Evidence**  \n- *HFE* (Entrez 3077) – gene affected by the variants  \n- IgC1_MHC_Ib_HLA‑H (CDD cd21021) – MHC‑I signature present in the encoded protein  \n\n**Details**  \n\n| Variant ID      | Chromosome | Position | Gene | Protein | Signature |\n|-----------------|------------|----------|------|---------|-----------|\n| clinvar.3061479 | 6          | 26 087 457 | HFE | B4DV50_HUMAN | IgC1_MHC_Ib_HLA‑H |\n| clinvar.1156873 | 6          | 26 087 446 | HFE | B4DV50_HUMAN | IgC1_MHC_Ib_HLA‑H |\n| clinvar.1710897 | 6          | 26 087 437 | HFE | B4DV50_HUMAN | IgC1_MHC_Ib_HLA‑H |\n\n(Additional variants with the same gene/ signature are also present.)",
  "context" : "[{\"variantId\": \"clinvar.3061479\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087457, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.1156873\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087446, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.1710897\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087437, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.906712\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087434, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.1320501\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087421, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.906711\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087393, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.906710\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087345, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.1204708\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26087031, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.1168055\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v.position\": 26086974, \"geneId\": \"entrez.3077\", \"geneName\": \"HFE\", \"proteinId\": \"uniprot.B4DV50\", \"proteinName\": \"B4DV50_HUMAN\", \"signatureId\": \"cdd.cd21021\", \"signatureName\": \"IgC1_MHC_Ib_HLA-H\"}, {\"variantId\": \"clinvar.356209\", \"variantName\": null, \"v.variantType\": \"Single Nucleotide Variant\", \"v.chromosome\": \"6\", \"v... (truncated)",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAffectsGene]->(g:Gene)-[:ProteinEncodedByGene]-(p:Protein)-[:ProteinHasSignature]->(s:Signature)\nWHERE s.primaryDomainId IN ['pfam.PF14586','cdd.cd21027','cdd.cd21021','pfam.PF09307','cdd.cd21000']\nRETURN v.primaryDomainId AS variantId,\n       v.displayName AS variantName,\n       v.variantType,\n       v.chromosome,\n       v.position,\n       g.primaryDomainId AS geneId,\n       g.displayName AS geneName,\n       p.primaryDomainId AS proteinId,\n       p.displayName AS proteinName,\n       s.primaryDomainId AS signatureId,\n       s.displayName AS signatureName;",
  "isCorrect" : true,
  "question" : "Are there any genomic variants affecting genes that encode proteins with the 'MHC_I' signature?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the protein/GO or pathway scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (p:Protein)-[:ProteinHasGOAnnotation]->(g:GO)\nWHERE toLower(g.displayName) CONTAINS 'nucleus'\nMATCH (p)-[:ProteinInPathway]->(pw:Pathway)\nWHERE toLower(pw.displayName) CONTAINS 'g protein-coupled receptor signaling pathway'\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, g.primaryDomainId AS goId, g.displayName AS goName, pw.primaryDomainId AS pathwayId, pw.displayName AS pathwayName;",
  "isCorrect" : false,
  "question" : "What proteins have the GO annotation 'nucleus' and are involved in the 'G protein-coupled receptor signaling pathway'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for the terms, broaden the scope of the query, or relax any filters that may be excluding relevant nodes.",
  "context" : "[]",
  "cypher" : "MATCH (gE:GO)\nWHERE toLower(gE.displayName) = toLower('extracellular exosome')\nMATCH (gR:GO)\nWHERE toLower(gR.displayName) = toLower('extracellular region')\nMATCH (t:GO)-[:GOIsSubtypeOfGO*]->(gE)\nMATCH (t)-[:GOIsSubtypeOfGO*]->(gR)\nRETURN DISTINCT t.primaryDomainId AS termId, t.displayName AS termName",
  "isCorrect" : false,
  "question" : "Are there any GO terms related to 'extracellular exosome' that are also subtypes of 'extracellular region'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe graph indicates that there is no direct subtype (parent‑child) relationship between the GO terms *ATP binding* (GO:0005524) and *DNA binding* (GO:0003677).  \n\n**Evidence:**  \n- *ATP binding* (GO:0005524) – queried term  \n- *DNA binding* (GO:0003677) – queried term  \n- Relationship status – “No direct subtype relationship found”  \n\n**Details**  \n\n| GO Term 1 (ID) | GO Term 2 (ID) | Relationship |\n|----------------|----------------|--------------|\n| ATP binding (GO:0005524) | DNA binding (GO:0003677) | No direct subtype relationship found |",
  "context" : "[{\"g1Id\": \"go.0005524\", \"g1Name\": \"ATP binding\", \"g2Id\": \"go.0003677\", \"g2Name\": \"DNA binding\", \"relationship\": \"No direct subtype relationship found\"}]",
  "cypher" : "MATCH (g1:GO),(g2:GO)\nWHERE toLower(g1.displayName)=toLower('ATP binding')\n  AND toLower(g2.displayName)=toLower('DNA binding')\nOPTIONAL MATCH path1 = (g1)-[:GOIsSubtypeOfGO*]->(g2)\nOPTIONAL MATCH path2 = (g2)-[:GOIsSubtypeOfGO*]->(g1)\nRETURN g1.primaryDomainId AS g1Id,\n       g1.displayName AS g1Name,\n       g2.primaryDomainId AS g2Id,\n       g2.displayName AS g2Name,\n       CASE\n         WHEN path1 IS NOT NULL THEN 'ATP binding is a subtype of DNA binding'\n         WHEN path2 IS NOT NULL THEN 'DNA binding is a subtype of ATP binding'\n         ELSE 'No direct subtype relationship found'\n       END AS relationship;",
  "isCorrect" : true,
  "question" : "What is the relationship between the GO terms 'ATP binding' and 'DNA binding' in the GO hierarchy?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe proteins that carry the GO annotation “nucleus” and participate in the “Signaling by GPCR” pathway are:  \nDGKB (UniProt Q9Y6T7), AKT3 (Q9Y243), KCC2A (Q9UQM7), PPR1B (Q9UD71), RGS17 (Q9UGC6), PLCB1 (Q9NQ66), TRPC7 (Q9HCX4), GPER1 (Q99527), KKCC2 (Q96RR4), PI3R5 (Q8WYR1), KKCC1 (Q8N5S9), RGS22 (Q8NE09) and HUNIN (Q8IVG9).  \n\n**Evidence:**  \n- DGKB (UniProt Q9Y6T7) – nucleus GO annotation, Signaling by GPCR pathway  \n- AKT3 (UniProt Q9Y243) – nucleus GO annotation, Signaling by GPCR pathway  \n- KCC2A (UniProt Q9UQM7) – nucleus GO annotation, Signaling by GPCR pathway  \n- PPR1B (UniProt Q9UD71) – nucleus GO annotation, Signaling by GPCR pathway  \n- RGS17 (UniProt Q9UGC6) – nucleus GO annotation, Signaling by GPCR pathway  \n- PLCB1 (UniProt Q9NQ66) – nucleus GO annotation, Signaling by GPCR pathway  \n- TRPC7 (UniProt Q9HCX4) – nucleus GO annotation, Signaling by GPCR pathway  \n- GPER1 (UniProt Q99527) – nucleus GO annotation, Signaling by GPCR pathway  \n- KKCC2 (UniProt Q96RR4) – nucleus GO annotation, Signaling by GPCR pathway  \n- PI3R5 (UniProt Q8WYR1) – nucleus GO annotation, Signaling by GPCR pathway  \n- KKCC1 (UniProt Q8N5S9) – nucleus GO annotation, Signaling by GPCR pathway  \n- RGS22 (UniProt Q8NE09) – nucleus GO annotation, Signaling by GPCR pathway  \n- HUNIN (UniProt Q8IVG9) – nucleus GO annotation, Signaling by GPCR pathway  \n\n**Details (table)**  \n\n| Protein (UniProt ID) | GO annotation | Pathway |\n|----------------------|---------------|---------|\n| DGKB (Q9Y6T7) | nucleus | Signaling by GPCR |\n| AKT3 (Q9Y243) | nucleus | Signaling by GPCR |\n| KCC2A (Q9UQM7) | nucleus | Signaling by GPCR |\n| PPR1B (Q9UD71) | nucleus | Signaling by GPCR |\n| RGS17 (Q9UGC6) | nucleus | Signaling by GPCR |\n| PLCB1 (Q9NQ66) | nucleus | Signaling by GPCR |\n| TRPC7 (Q9HCX4) | nucleus | Signaling by GPCR |\n| GPER1 (Q99527) | nucleus | Signaling by GPCR |\n| KKCC2 (Q96RR4) | nucleus | Signaling by GPCR |\n| PI3R5 (Q8WYR1) | nucleus | Signaling by GPCR |\n| KKCC1 (Q8N5S9) | nucleus | Signaling by GPCR |\n| RGS22 (Q8NE09) | nucleus | Signaling by GPCR |\n| HUNIN (Q8IVG9) | nucleus | Signaling by GPCR |",
  "context" : "[{\"proteinId\": \"uniprot.Q9Y6T7\", \"proteinName\": \"DGKB_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9Y243\", \"proteinName\": \"AKT3_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9UD71\", \"proteinName\": \"PPR1B_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9UGC6\", \"proteinName\": \"RGS17_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9NQ66\", \"proteinName\": \"PLCB1_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q9HCX4\", \"proteinName\": \"TRPC7_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q99527\", \"proteinName\": \"GPER1_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q99835\", \"proteinName\": \"SMO_HUMAN\", \"goId\": \"go.0006606\", \"goName\": \"protein import into nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q99835\", \"proteinName\": \"SMO_HUMAN\", \"goId\": \"go.0042307\", \"goName\": \"positive regulation of protein import into nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q99835\", \"proteinName\": \"SMO_HUMAN\", \"goId\": \"go.0034504\", \"goName\": \"protein localization to nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q96RR4\", \"proteinName\": \"KKCC2_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q8WYR1\", \"proteinName\": \"PI3R5_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q8N5S9\", \"proteinName\": \"KKCC1_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q8NE09\", \"proteinName\": \"RGS22_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q8IVG9\", \"proteinName\": \"HUNIN_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\", \"pathwayId\": \"reactome.R-HSA-372790\", \"pathwayName\": \"Signaling by GPCR\"}, {\"proteinId\": \"uniprot.Q7Z6J4\", \"protein... (truncated)",
  "cypher" : "MATCH (p:Protein)-[:ProteinHasGOAnnotation]->(g:GO)\nWHERE toLower(g.displayName) CONTAINS 'nucleus'\nMATCH (p)-[:ProteinInPathway]->(path:Pathway)\nWHERE toLower(path.displayName) CONTAINS 'gpcr' AND toLower(path.displayName) CONTAINS 'signaling'\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName,\n       g.primaryDomainId AS goId, g.displayName AS goName,\n       path.primaryDomainId AS pathwayId, path.displayName AS pathwayName;",
  "isCorrect" : true,
  "question" : "Which proteins have the GO annotation 'nucleus' and are involved in the 'G protein-coupled receptor signaling pathway'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe Gene Ontology (GO) term “plasma membrane” (go.0005886) is defined as *“The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.”* The information for this term comes from the Gene Ontology database itself.\n\n**Evidence:**  \n- plasma membrane (go.0005886) – description as above  \n- data source: Gene Ontology (go)\n\n**Details**\n\n| GO ID      | Name            | Description                                                                                                            | Data Sources |\n|------------|-----------------|--------------------------------------------------------------------------------------------------------------------------|--------------|\n| go.0005886 | plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. | go           |",
  "context" : "[{\"goId\": \"go.0005886\", \"goName\": \"plasma membrane\", \"goDescription\": \"The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.\", \"goDataSources\": [\"go\"]}]",
  "cypher" : "MATCH (g:GO)\nWHERE toLower(g.displayName) = toLower('plasma membrane')\nRETURN g.primaryDomainId AS goId, g.displayName AS goName, g.description AS goDescription, g.dataSources AS goDataSources",
  "isCorrect" : true,
  "question" : "What are the descriptions and data sources associated with the GO term 'plasma membrane'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for the GO term, broaden the search scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (g:GO)\nWHERE g.primaryDomainId IN ['go.0006357','go.0045944','go.0090575','go.0060260','go.0060962']\nMATCH (g)-[:ProteinHasGOAnnotation]->(p:Protein)-[:ProteinEncodedByGene]->(gene:Gene)\nRETURN DISTINCT g.primaryDomainId AS goId, g.displayName AS goName, gene.primaryDomainId AS geneId, gene.displayName AS geneName",
  "isCorrect" : false,
  "question" : "Find all GO terms related to 'regulation of transcription by RNA polymerase II' and their corresponding genes.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No relevant nodes were provided for this question.  \nEvidence: None.  \nNext steps: Add authoritative identifiers (e.g., UniProt for proteins, GO for annotations, Reactome for pathways) or provide explicit associations between proteins and the GO term 'metal ion binding'.",
  "context" : "Node Type: go\nNode Value: metal ion binding\nSub Question: annotated proteins\nNeeds Filter: null\nEnhanced Nodes:\n  - Primary Domain ID: go.0046872\n    Display Name: metal ion binding\n    Description: Binding to a metal ion.\n  - Primary Domain ID: go.0030350\n    Display Name: iron-responsive element binding\n    Description: Binding to an iron-responsive element, a regulatory sequence found in the 5'- and 3'-untranslated regions of mRNAs encoding many iron-binding proteins.\n  - Primary Domain ID: go.0046914\n    Display Name: transition metal ion binding\n    Description: Binding to a transition metal ions; a transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons, or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium, manganese, iron, copper, cobalt, nickel, molybdenum and silver.\n  - Primary Domain ID: go.0140784\n    Display Name: metal ion sensor activity\n    Description: Binding to and responding, e.g. by conformational change, to changes in the cellular level of a metal ion.\n  - Primary Domain ID: go.0030145\n    Display Name: manganese ion binding\n    Description: Binding to a manganese ion (Mn).\n\nNode Type: protein\nNode Value: proteins\nSub Question: annotated with GO term\nNeeds Filter: null\nEnhanced Nodes:\n  - Primary Domain ID: uniprot.A0A6Q8PGR1\n    Display Name: A0A6Q8PGR1_HUMAN\n    Synonyms: G protein subunit alpha o1\n  - Primary Domain ID: uniprot.A0A8Q3SHQ4\n    Display Name: A0A8Q3SHQ4_HUMAN\n    Synonyms: Golgin B1\n  - Primary Domain ID: uniprot.C9J8Q0\n    Display Name: C9J8Q0_HUMAN\n    Synonyms: Golgin B1\n  - Primary Domain ID: uniprot.A0A1W2PQK2\n    Display Name: A0A1W2PQK2_HUMAN\n    Synonyms: G protein subunit alpha o1\n  - Primary Domain ID: uniprot.A0A8I5KRU0\n    Display Name: A0A8I5KRU0_HUMAN\n    Synonyms: Golgin A2\n\nNode Type: pathway\nNode Value: pathways\nSub Question: associated with proteins\nNeeds Filter: null\nEnhanced Nodes:\n  - Primary Domain ID: reactome.R-HSA-392499\n    Display Name: Metabolism of proteins\n  - Primary Domain ID: reactome.R-HSA-9609507\n    Display Name: Protein localization\n  - Primary Domain ID: reactome.R-HSA-5689603\n    Display Name: UCH proteinases\n  - Primary Domain ID: reactome.R-HSA-4608870\n    Display Name: Asymmetric localization of PCP proteins\n  - Primary Domain ID: reactome.R-HSA-9694635\n    Display Name: Translation of Structural Proteins\n\n",
  "cypher" : null,
  "isCorrect" : true,
  "question" : "List all proteins annotated with the GO term 'metal ion binding' and their associated pathways.",
  "attempt" : 0,
  "fallback" : true
}, {
  "answer" : "**Answer:**  \nThe amino‑acid sequence of the human MYC protein (UniProt ID P01106) is:\n\nMDFFRVVENQQPPATMPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA  \n\n**Evidence**  \n• MYC_HUMAN (UniProt P01106) – amino‑acid sequence  \n\n**Details** (none needed; single entry).",
  "context" : "[{\"proteinId\": \"uniprot.P01106\", \"proteinName\": \"MYC_HUMAN\", \"aminoAcidSequence\": \"MDFFRVVENQQPPATMPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA\"}]",
  "cypher" : "MATCH (p:Protein)\nWHERE toLower(p.displayName) = toLower('MYC_HUMAN')\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, p.sequence AS aminoAcidSequence;",
  "isCorrect" : true,
  "question" : "What is the amino acid sequence of the protein MYC_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: The protein **1433E_HUMAN** is encoded by the gene **YWHAE** (Entrez ID 7531).\n\nEvidence:\n- **YWHAE** (Entrez:7531) – encodes 1433E_HUMAN",
  "context" : "[{\"geneId\": \"entrez.7531\", \"geneName\": \"YWHAE\"}]",
  "cypher" : "MATCH (p:Protein)-[:ProteinEncodedByGene]->(g:Gene)\nWHERE toLower(p.displayName) = toLower('1433E_HUMAN')\nRETURN g.primaryDomainId AS geneId, g.displayName AS geneName;",
  "isCorrect" : true,
  "question" : "What genes encode the protein 1433E_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nCUL3_HUMAN is associated with a wide array of protein‑domain and family signatures from several databases, including Prosite, Supfam, SMART, Pfam, Panther, InterPro, and Gene3D. These signatures capture its Cullin domain architecture, neddylation domain, and related structural motifs.\n\n**Evidence:**  \n- **CULLIN_2** (prosite.PS50069)  \n- **CULLIN_1** (prosite.PS01256)  \n- **Winge** (supfam.SSF46785)  \n- **Culli** (supfam.SSF74788)  \n- **Culli** (supfam.SSF75632)  \n- **Cullin_Nedd8** (smart.SM00884)  \n- **CULLIN** (smart.SM00182)  \n- **Cullin_Nedd8** (pfam.PF10557)  \n- **Cullin** (pfam.PF00888)  \n- **CULLIN** (panther.PTHR11932)  \n- **WH_DNA‑bd_sf** (interpro.IPR036390)  \n- **WH‑like_DNA‑bd_sf** (interpro.IPR036388)  \n- **Cullin_repeat‑like_dom_sf** (interpro.IPR016159)  \n- **Cullin_neddylation_domain** (interpro.IPR019559)  \n- **Cullin_N** (interpro.IPR001373)  \n- **Cullin_homology_sf** (interpro.IPR036317)  \n- **Cullin_homology** (interpro.IPR016158)  \n- **Cullin_CS** (interpro.IPR016157)  \n- **Cullin** (interpro.IPR045093)  \n- **Winge** (gene3d.1.10.10.10)  \n- **Cullin** (gene3d.3.30.230.130)  \n- **Culli** (gene3d.1.20.1310.10)\n\n**Details (table):**\n\n| Signature ID                | Signature Name              |\n|-----------------------------|-----------------------------|\n| prosite.PS50069             | CULLIN_2                    |\n| prosite.PS01256             | CULLIN_1                    |\n| supfam.SSF46785             | Winge                       |\n| supfam.SSF74788             | Culli                       |\n| supfam.SSF75632             | Culli                       |\n| smart.SM00884               | Cullin_Nedd8                |\n| smart.SM00182               | CULLIN                      |\n| pfam.PF10557                | Cullin_Nedd8                |\n| pfam.PF00888                | Cullin                      |\n| panther.PTHR11932           | CULLIN                      |\n| interpro.IPR036390          | WH_DNA‑bd_sf                |\n| interpro.IPR036388          | WH‑like_DNA‑bd_sf           |\n| interpro.IPR016159          | Cullin_repeat‑like_dom_sf   |\n| interpro.IPR019559          | Cullin_neddylation_domain   |\n| interpro.IPR001373          | Cullin_N                    |\n| interpro.IPR036317          | Cullin_homology_sf          |\n| interpro.IPR016158          | Cullin_homology             |\n| interpro.IPR016157          | Cullin_CS                   |\n| interpro.IPR045093          | Cullin                      |\n| gene3d.1.10.10.10           | Winge                       |\n| gene3d.3.30.230.130         | Cullin                      |\n| gene3d.1.20.1310.10         | Culli                       |",
  "context" : "[{\"signatureId\": \"prosite.PS50069\", \"signatureName\": \"CULLIN_2\"}, {\"signatureId\": \"prosite.PS01256\", \"signatureName\": \"CULLIN_1\"}, {\"signatureId\": \"supfam.SSF46785\", \"signatureName\": \"Winge\"}, {\"signatureId\": \"supfam.SSF74788\", \"signatureName\": \"Culli\"}, {\"signatureId\": \"supfam.SSF75632\", \"signatureName\": \"Culli\"}, {\"signatureId\": \"smart.SM00884\", \"signatureName\": \"Cullin_Nedd8\"}, {\"signatureId\": \"smart.SM00182\", \"signatureName\": \"CULLIN\"}, {\"signatureId\": \"pfam.PF10557\", \"signatureName\": \"Cullin_Nedd8\"}, {\"signatureId\": \"pfam.PF00888\", \"signatureName\": \"Cullin\"}, {\"signatureId\": \"panther.PTHR11932\", \"signatureName\": \"CULLIN\"}, {\"signatureId\": \"interpro.IPR036390\", \"signatureName\": \"WH_DNA-bd_sf\"}, {\"signatureId\": \"interpro.IPR036388\", \"signatureName\": \"WH-like_DNA-bd_sf\"}, {\"signatureId\": \"interpro.IPR016159\", \"signatureName\": \"Cullin_repeat-like_dom_sf\"}, {\"signatureId\": \"interpro.IPR019559\", \"signatureName\": \"Cullin_neddylation_domain\"}, {\"signatureId\": \"interpro.IPR001373\", \"signatureName\": \"Cullin_N\"}, {\"signatureId\": \"interpro.IPR036317\", \"signatureName\": \"Cullin_homology_sf\"}, {\"signatureId\": \"interpro.IPR016158\", \"signatureName\": \"Cullin_homology\"}, {\"signatureId\": \"interpro.IPR016157\", \"signatureName\": \"Cullin_CS\"}, {\"signatureId\": \"interpro.IPR045093\", \"signatureName\": \"Cullin\"}, {\"signatureId\": \"gene3d.1.10.10.10\", \"signatureName\": \"Winge\"}, {\"signatureId\": \"gene3d.3.30.230.130\", \"signatureName\": \"Cullin\"}, {\"signatureId\": \"gene3d.1.20.1310.10\", \"signatureName\": \"Culli\"}]",
  "cypher" : "MATCH (p:Protein)-[:ProteinHasSignature]->(s:Signature)\nWHERE toLower(p.displayName) = toLower('CUL3_HUMAN')\nRETURN s.primaryDomainId AS signatureId, s.displayName AS signatureName;",
  "isCorrect" : true,
  "question" : "What are the signatures associated with the protein CUL3_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nP53_HUMAN (UniProt ID P04637) is annotated with a broad range of Gene Ontology (GO) terms, covering cellular component, molecular function, and biological process categories. The annotations include terms such as “protein‑containing complex,” “transcription repressor complex,” “nucleus,” “mitochondrion,” and several apoptosis‑related processes.\n\n**Evidence:**  \n- **P53_HUMAN** (uniprot.P04637) – GO annotations  \n\n**Details**\n\n| GO ID      | GO Name                                 |\n|------------|------------------------------------------|\n| go.0032991 | protein‑containing complex              |\n| go.0017053 | transcription repressor complex         |\n| go.0005667 | transcription regulator complex         |\n| go.0043073 | germ cell nucleus                       |\n| go.0035861 | site of double‑strand break              |\n| go.0016605 | PML body                                |\n| go.0016363 | nuclear matrix                          |\n| go.0005856 | cytoskeleton                            |\n| go.0005829 | cytosol                                 |\n| go.0005813 | centrosome                              |\n| go.0005783 | endoplasmic reticulum                   |\n| go.0005759 | mitochondrial matrix                    |\n| go.0005739 | mitochondrion                           |\n| go.0005737 | cytoplasm                               |\n| go.0005730 | nucleolus                               |\n| go.0005657 | replication fork                        |\n| go.0005654 | nucleoplasm                             |\n| go.0000785 | chromatin                               |\n| go.0005634 | nucleus                                 |\n| go.2001244 | positive regulation of intrinsic apoptotic signaling pathway |\n| go.2001242 | regulation of intrinsic apoptotic signaling pathway |\n| go.2000774 | positive regulation of cellular senescence |\n| go.2000379 | positive regulation of reactive oxygen species metabolic process |\n| go.1905856 | negative regulation of pentose‑phosphate shunt |\n| go.1903451 | negative regulation of ... (truncated)  |\n\n*(The list is truncated in the Neo4j output; all returned rows are included above.)*",
  "context" : "[{\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0032991\", \"goName\": \"protein-containing complex\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0017053\", \"goName\": \"transcription repressor complex\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005667\", \"goName\": \"transcription regulator complex\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0043073\", \"goName\": \"germ cell nucleus\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0035861\", \"goName\": \"site of double-strand break\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0016605\", \"goName\": \"PML body\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0016363\", \"goName\": \"nuclear matrix\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005856\", \"goName\": \"cytoskeleton\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005829\", \"goName\": \"cytosol\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005813\", \"goName\": \"centrosome\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005783\", \"goName\": \"endoplasmic reticulum\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005759\", \"goName\": \"mitochondrial matrix\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005739\", \"goName\": \"mitochondrion\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005737\", \"goName\": \"cytoplasm\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005730\", \"goName\": \"nucleolus\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005657\", \"goName\": \"replication fork\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005654\", \"goName\": \"nucleoplasm\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0000785\", \"goName\": \"chromatin\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.0005634\", \"goName\": \"nucleus\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.2001244\", \"goName\": \"positive regulation of intrinsic apoptotic signaling pathway\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.2001242\", \"goName\": \"regulation of intrinsic apoptotic signaling pathway\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.2000774\", \"goName\": \"positive regulation of cellular senescence\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.2000379\", \"goName\": \"positive regulation of reactive oxygen species metabolic process\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.1905856\", \"goName\": \"negative regulation of pentose-phosphate shunt\"}, {\"proteinId\": \"uniprot.P04637\", \"proteinName\": \"P53_HUMAN\", \"goId\": \"go.1903451\", \"goName\": \"negative regulati... (truncated)",
  "cypher" : "MATCH (p:Protein)-[:ProteinHasGOAnnotation]->(go:GO)\nWHERE toLower(p.displayName) = toLower('P53_HUMAN')\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, go.primaryDomainId AS goId, go.displayName AS goName",
  "isCorrect" : true,
  "question" : "What are the GO annotations for the protein P53_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nProteins that have a recorded interaction with **TRI67_HUMAN** include the following UniProt‑annotated proteins:\n\n| Protein (Human) | UniProt ID |\n|-----------------|------------|\n| MASP1_HUMAN | P48740 |\n| MCP_HUMAN | P15529 |\n| TENX_HUMAN | P22105 |\n| NCAM2_HUMAN | O15394 |\n| SDK2_HUMAN | Q58EX2 |\n| PTPRD_HUMAN | P23468 |\n| CDON_HUMAN | Q4KMG0 |\n| P85A_HUMAN | P27986 |\n| GRB7_HUMAN | Q14451 |\n| IL4RA_HUMAN | P24394 |\n| EPHAA_HUMAN | Q5JZY3 |\n| EPHB1_HUMAN | P54762 |\n| DSCAM_HUMAN | O60469 |\n| PTPRS_HUMAN | Q13332 |\n| B6D4Y2_HUMAN | B6D4Y2 |\n| LRP6_HUMAN | O75581 |\n| RPAB3_HUMAN | P52434 |\n| SHRM2_HUMAN | Q13796 |\n| B4DP73_HUMAN | B4DP73 |\n| F6RTR7_HUMAN | F6RTR7 |\n| B4DU97_HUMAN | B4DU97 |\n| PM34_HUMAN | O43808 |\n| CH3L1_HUMAN | P36222 |\n| 2A5A_HUMAN | Q15172 |\n| ERCC2_HUMAN | P18074 |\n| ZSWM8_HUMAN | A7E2V4 |\n| L7RSL8_HUMAN | L7RSL8 |\n| I1SRC5_HUMAN | I1SRC5 |\n| RASK_HUMAN | P01116 |\n| J3KNN3_HUMAN | J3KNN3 |\n| PHKG2_HUMAN | P15735 |\n| LCLT1_HUMAN | Q6UWP7 |\n| B4DSG5_HUMAN | B4DSG5 |\n| E5RGY0_HUMAN | E5RGY0 |\n| PJA2_HUMAN | O43164 |\n| B3KWP1_HUMAN | B3KWP1 |\n| E9PAJ1_HUMAN | E9PAJ1 |\n| PSB8_HUMAN | P28062 |\n| B3KTL0_HUMAN | B3KTL0 |\n| MBRL_HUMAN | Q4ZIN3 |\n| A4ZI32_HUMAN | A4ZI32 |\n| FP100_HUMAN | Q0VG06 |\n| CLCN6_HUMAN | P51797 |\n| A0A087WYT5_HUMAN | A0A087WYT5 |\n| RAB4A_HUMAN | P20338 |\n| A0A5E8_HUMAN | A0A5E8 |\n| PPIC_HUMAN | P45877 |\n| (additional partner) | O14775 |\n\n**Evidence:**\n- MASP1 (UniProt: P48740) – interacts with TRI67_HUMAN  \n- MCP (UniProt: P15529) – interacts with TRI67_HUMAN  \n- TENX (UniProt: P22105) – interacts with TRI67_HUMAN  \n- NCAM2 (UniProt: O15394) – interacts with TRI67_HUMAN  \n- SDK2 (UniProt: Q58EX2) – interacts with TRI67_HUMAN  \n- PTPRD (UniProt: P23468) – interacts with TRI67_HUMAN  \n- CDON (UniProt: Q4KMG0) – interacts with TRI67_HUMAN  \n- P85A (UniProt: P27986) – interacts with TRI67_HUMAN  \n- GRB7 (UniProt: Q14451) – interacts with TRI67_HUMAN  \n- IL4RA (UniProt: P24394) – interacts with TRI67_HUMAN  \n- EPHAA (UniProt: Q5JZY3) – interacts with TRI67_HUMAN  \n- EPHB1 (UniProt: P54762) – interacts with TRI67_HUMAN  \n- DSCAM (UniProt: O60469) – interacts with TRI67_HUMAN  \n- PTPRS (UniProt: Q13332) – interacts with TRI67_HUMAN  \n- B6D4Y2 (UniProt: B6D4Y2) – interacts with TRI67_HUMAN  \n- LRP6 (UniProt: O75581) – interacts with TRI67_HUMAN  \n- RPAB3 (UniProt: P52434) – interacts with TRI67_HUMAN  \n- SHRM2 (UniProt: Q13796) – interacts with TRI67_HUMAN  \n- B4DP73 (UniProt: B4DP73) – interacts with TRI67_HUMAN  \n- F6RTR7 (UniProt: F6RTR7) – interacts with TRI67_HUMAN  \n- B4DU97 (UniProt: B4DU97) – interacts with TRI67_HUMAN  \n- PM34 (UniProt: O43808) – interacts with TRI67_HUMAN  \n- CH3L1 (UniProt: P36222) – interacts with TRI67_HUMAN  \n- 2A5A (UniProt: Q15172) – interacts with TRI67_HUMAN  \n- ERCC2 (UniProt: P18074) – interacts with TRI67_HUMAN  \n- ZSWM8 (UniProt: A7E2V4) – interacts with TRI67_HUMAN  \n- L7RSL8 (UniProt: L7RSL8) – interacts with TRI67_HUMAN  \n- I1SRC5 (UniProt: I1SRC5) – interacts with TRI67_HUMAN  \n- RASK (UniProt: P01116) – interacts with TRI67_HUMAN  \n- J3KNN3 (UniProt: J3KNN3) – interacts with TRI67_HUMAN  \n- PHKG2 (UniProt: P15735) – interacts with TRI67_HUMAN  \n- LCLT1 (UniProt: Q6UWP7) – interacts with TRI67_HUMAN  \n- B4DSG5 (UniProt: B4DSG5) – interacts with TRI67_HUMAN  \n- E5RGY0 (UniProt: E5RGY0) – interacts with TRI67_HUMAN  \n- PJA2 (UniProt: O43164) – interacts with TRI67_HUMAN  \n- B3KWP1 (UniProt: B3KWP1) – interacts with TRI67_HUMAN  \n- E9PAJ1 (UniProt: E9PAJ1) – interacts with TRI67_HUMAN  \n- PSB8 (UniProt: P28062) – interacts with TRI67_HUMAN  \n- B3KTL0 (UniProt: B3KTL0) – interacts with TRI67_HUMAN  \n- MBRL (UniProt: Q4ZIN3) – interacts with TRI67_HUMAN  \n- A4ZI32 (UniProt: A4ZI32) – interacts with TRI67_HUMAN  \n- FP100 (UniProt: Q0VG06) – interacts with TRI67_HUMAN  \n- CLCN6 (UniProt: P51797) – interacts with TRI67_HUMAN  \n- A0A087WYT5 (UniProt: A0A087WYT5) – interacts with TRI67_HUMAN  \n- RAB4A (UniProt: P20338) – interacts with TRI67_HUMAN  \n- A0A5E8 (UniProt: A0A5E8) – interacts with TRI67_HUMAN  \n- PPIC (UniProt: P45877) – interacts with TRI67_HUMAN  \n- (additional partner) (UniProt: O14775) – interacts with TRI67_HUMAN  \n\nThese are all the interaction partners reported for TRI67_HUMAN in the supplied Neo4j result.",
  "context" : "[{\"partnerId\": \"uniprot.P48740\", \"partnerName\": \"MASP1_HUMAN\"}, {\"partnerId\": \"uniprot.P15529\", \"partnerName\": \"MCP_HUMAN\"}, {\"partnerId\": \"uniprot.P22105\", \"partnerName\": \"TENX_HUMAN\"}, {\"partnerId\": \"uniprot.O15394\", \"partnerName\": \"NCAM2_HUMAN\"}, {\"partnerId\": \"uniprot.Q58EX2\", \"partnerName\": \"SDK2_HUMAN\"}, {\"partnerId\": \"uniprot.P23468\", \"partnerName\": \"PTPRD_HUMAN\"}, {\"partnerId\": \"uniprot.Q4KMG0\", \"partnerName\": \"CDON_HUMAN\"}, {\"partnerId\": \"uniprot.P27986\", \"partnerName\": \"P85A_HUMAN\"}, {\"partnerId\": \"uniprot.Q14451\", \"partnerName\": \"GRB7_HUMAN\"}, {\"partnerId\": \"uniprot.P24394\", \"partnerName\": \"IL4RA_HUMAN\"}, {\"partnerId\": \"uniprot.Q5JZY3\", \"partnerName\": \"EPHAA_HUMAN\"}, {\"partnerId\": \"uniprot.P54762\", \"partnerName\": \"EPHB1_HUMAN\"}, {\"partnerId\": \"uniprot.O60469\", \"partnerName\": \"DSCAM_HUMAN\"}, {\"partnerId\": \"uniprot.Q13332\", \"partnerName\": \"PTPRS_HUMAN\"}, {\"partnerId\": \"uniprot.B6D4Y2\", \"partnerName\": \"B6D4Y2_HUMAN\"}, {\"partnerId\": \"uniprot.O75581\", \"partnerName\": \"LRP6_HUMAN\"}, {\"partnerId\": \"uniprot.P52434\", \"partnerName\": \"RPAB3_HUMAN\"}, {\"partnerId\": \"uniprot.Q13796\", \"partnerName\": \"SHRM2_HUMAN\"}, {\"partnerId\": \"uniprot.B4DP73\", \"partnerName\": \"B4DP73_HUMAN\"}, {\"partnerId\": \"uniprot.F6RTR7\", \"partnerName\": \"F6RTR7_HUMAN\"}, {\"partnerId\": \"uniprot.B4DU97\", \"partnerName\": \"B4DU97_HUMAN\"}, {\"partnerId\": \"uniprot.O43808\", \"partnerName\": \"PM34_HUMAN\"}, {\"partnerId\": \"uniprot.P36222\", \"partnerName\": \"CH3L1_HUMAN\"}, {\"partnerId\": \"uniprot.Q15172\", \"partnerName\": \"2A5A_HUMAN\"}, {\"partnerId\": \"uniprot.P18074\", \"partnerName\": \"ERCC2_HUMAN\"}, {\"partnerId\": \"uniprot.A7E2V4\", \"partnerName\": \"ZSWM8_HUMAN\"}, {\"partnerId\": \"uniprot.L7RSL8\", \"partnerName\": \"L7RSL8_HUMAN\"}, {\"partnerId\": \"uniprot.I1SRC5\", \"partnerName\": \"I1SRC5_HUMAN\"}, {\"partnerId\": \"uniprot.P01116\", \"partnerName\": \"RASK_HUMAN\"}, {\"partnerId\": \"uniprot.J3KNN3\", \"partnerName\": \"J3KNN3_HUMAN\"}, {\"partnerId\": \"uniprot.P15735\", \"partnerName\": \"PHKG2_HUMAN\"}, {\"partnerId\": \"uniprot.Q6UWP7\", \"partnerName\": \"LCLT1_HUMAN\"}, {\"partnerId\": \"uniprot.B4DSG5\", \"partnerName\": \"B4DSG5_HUMAN\"}, {\"partnerId\": \"uniprot.E5RGY0\", \"partnerName\": \"E5RGY0_HUMAN\"}, {\"partnerId\": \"uniprot.O43164\", \"partnerName\": \"PJA2_HUMAN\"}, {\"partnerId\": \"uniprot.B3KWP1\", \"partnerName\": \"B3KWP1_HUMAN\"}, {\"partnerId\": \"uniprot.E9PAJ1\", \"partnerName\": \"E9PAJ1_HUMAN\"}, {\"partnerId\": \"uniprot.P28062\", \"partnerName\": \"PSB8_HUMAN\"}, {\"partnerId\": \"uniprot.B3KTL0\", \"partnerName\": \"B3KTL0_HUMAN\"}, {\"partnerId\": \"uniprot.Q4ZIN3\", \"partnerName\": \"MBRL_HUMAN\"}, {\"partnerId\": \"uniprot.A4ZI32\", \"partnerName\": \"A4ZI32_HUMAN\"}, {\"partnerId\": \"uniprot.Q0VG06\", \"partnerName\": \"FP100_HUMAN\"}, {\"partnerId\": \"uniprot.P51797\", \"partnerName\": \"CLCN6_HUMAN\"}, {\"partnerId\": \"uniprot.A0A087WYT5\", \"partnerName\": \"A0A087WYT5_HUMAN\"}, {\"partnerId\": \"uniprot.P20338\", \"partnerName\": \"RAB4A_HUMAN\"}, {\"partnerId\": \"uniprot.A0A5E8\", \"partnerName\": \"A0A5E8_HUMAN\"}, {\"partnerId\": \"uniprot.P45877\", \"partnerName\": \"PPIC_HUMAN\"}, {\"partnerId\": \"uniprot.O14775\"... (truncated)",
  "cypher" : "MATCH (tri:Protein) WHERE toLower(tri.displayName) = toLower('TRI67_HUMAN')\nMATCH (tri)-[:ProteinInteractsWithProtein]-(partner:Protein)\nRETURN partner.primaryDomainId AS partnerId, partner.displayName AS partnerName;",
  "isCorrect" : true,
  "question" : "Which proteins interact with TRI67_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe amino‑acid sequence of the protein **EGFR_HUMAN** (UniProt ID P00533) is the following 1,386‑residue string:\n\nMRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA\n\n**Evidence:**  \n- EGFR_HUMAN (uniprot.P00533) – protein identifier and name.  \n- aminoAcidSequence – the full sequence string provided for the protein.",
  "context" : "[{\"proteinId\": \"uniprot.P00533\", \"proteinName\": \"EGFR_HUMAN\", \"aminoAcidSequence\": \"MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA\"}]",
  "cypher" : "MATCH (p:Protein)\nWHERE toLower(p.displayName) = toLower('EGFR_HUMAN')\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, p.sequence AS aminoAcidSequence",
  "isCorrect" : true,
  "question" : "What is the amino acid sequence of the protein EGFR_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe human RFA1 protein (RFA1_HUMAN) is annotated with several domain and family signatures, such as Supfam, Pfam, Panther, InterPro, Gene3D, CDD, and others.  These signatures describe structural and functional motifs including nuclear localization signals, tRNA anti‑codon binding domains, and replication factor A (RPA1) DNA‑binding motifs.\n\n**Evidence:**\n- supfam.SSF50249 – Nuclei  \n- pfam.PF01336 – tRNA_anti‑codon  \n- pfam.PF16900 – REPA_OB_2  \n- pfam.PF08646 – Rep_fac‑A_C  \n- pfam.PF04057 – Rep‑A_N  \n- panther.PTHR47165:SF4 – OS03G042990  \n- panther.PTHR47165 – OS03G042990  \n- interpro.IPR004591 – Rfa1  \n- interpro.IPR031657 – REPA_OB_2  \n- interpro.IPR007199 – Rep_factor‑A_N  \n- interpro.IPR013955 – Rep_factor‑A_C  \n- interpro.IPR004365 – NA‑bd_OB_tRNA  \n- interpro.IPR012340 – NA‑bd_OB‑fold  \n- interpro.IPR047192 – Euk_RPA1_DBD_C  \n- gene3d.2.40.50.140 – Nuclei  \n- cdd.cd04477 – RPA1N  \n- cdd.cd04476 – RPA1_DBD_C  \n- cdd.cd04475 – RPA1_DBD_B  \n- cdd.cd04474 – RPA1_DBD_A  \n\n**Details (table):**\n\n| Signature ID | Signature Name |\n|--------------|----------------|\n| supfam.SSF50249 | Nuclei |\n| pfam.PF01336 | tRNA_anti‑codon |\n| pfam.PF16900 | REPA_OB_2 |\n| pfam.PF08646 | Rep_fac‑A_C |\n| pfam.PF04057 | Rep‑A_N |\n| panther.PTHR47165:SF4 | OS03G042990 |\n| panther.PTHR47165 | OS03G042990 |\n| interpro.IPR004591 | Rfa1 |\n| interpro.IPR031657 | REPA_OB_2 |\n| interpro.IPR007199 | Rep_factor‑A_N |\n| interpro.IPR013955 | Rep_factor‑A_C |\n| interpro.IPR004365 | NA‑bd_OB_tRNA |\n| interpro.IPR012340 | NA‑bd_OB‑fold |\n| interpro.IPR047192 | Euk_RPA1_DBD_C |\n| gene3d.2.40.50.140 | Nuclei |\n| cdd.cd04477 | RPA1N |\n| cdd.cd04476 | RPA1_DBD_C |\n| cdd.cd04475 | RPA1_DBD_B |\n| cdd.cd04474 | RPA1_DBD_A |\n",
  "context" : "[{\"signatureId\": \"supfam.SSF50249\", \"signatureName\": \"Nuclei\"}, {\"signatureId\": \"pfam.PF01336\", \"signatureName\": \"tRNA_anti-codon\"}, {\"signatureId\": \"pfam.PF16900\", \"signatureName\": \"REPA_OB_2\"}, {\"signatureId\": \"pfam.PF08646\", \"signatureName\": \"Rep_fac-A_C\"}, {\"signatureId\": \"pfam.PF04057\", \"signatureName\": \"Rep-A_N\"}, {\"signatureId\": \"panther.PTHR47165:SF4\", \"signatureName\": \"OS03G042990\"}, {\"signatureId\": \"panther.PTHR47165\", \"signatureName\": \"OS03G042990\"}, {\"signatureId\": \"interpro.IPR004591\", \"signatureName\": \"Rfa1\"}, {\"signatureId\": \"interpro.IPR031657\", \"signatureName\": \"REPA_OB_2\"}, {\"signatureId\": \"interpro.IPR007199\", \"signatureName\": \"Rep_factor-A_N\"}, {\"signatureId\": \"interpro.IPR013955\", \"signatureName\": \"Rep_factor-A_C\"}, {\"signatureId\": \"interpro.IPR004365\", \"signatureName\": \"NA-bd_OB_tRNA\"}, {\"signatureId\": \"interpro.IPR012340\", \"signatureName\": \"NA-bd_OB-fold\"}, {\"signatureId\": \"interpro.IPR047192\", \"signatureName\": \"Euk_RPA1_DBD_C\"}, {\"signatureId\": \"gene3d.2.40.50.140\", \"signatureName\": \"Nuclei\"}, {\"signatureId\": \"cdd.cd04477\", \"signatureName\": \"RPA1N\"}, {\"signatureId\": \"cdd.cd04476\", \"signatureName\": \"RPA1_DBD_C\"}, {\"signatureId\": \"cdd.cd04475\", \"signatureName\": \"RPA1_DBD_B\"}, {\"signatureId\": \"cdd.cd04474\", \"signatureName\": \"RPA1_DBD_A\"}]",
  "cypher" : "MATCH (p:Protein)\nWHERE toLower(p.displayName) = toLower('RFA1_HUMAN')\nMATCH (p)-[:ProteinHasSignature]->(s:Signature)\nRETURN s.primaryDomainId AS signatureId, s.displayName AS signatureName;",
  "isCorrect" : true,
  "question" : "What are the known signatures for the protein RFA1_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (p:Protein {primaryDomainId:'uniprot.Q14228'})<-[:ProteinEncodedByGene]-(g:Gene) RETURN g.primaryDomainId AS geneId, g.displayName AS geneName;",
  "isCorrect" : true,
  "question" : "What gene encodes the protein ESR1_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe protein *HSP7C_HUMAN* (UniProt ID P11142) has the following synonyms:  \n- LPS‑associated protein 1  \n- 3.6.4.10  \n- Heat shock 70 kDa protein 8  \n- Heat shock cognate 71 kDa protein  \n- LAP‑1  \n- Heat shock protein family A member 8  \n- Lipopolysaccharide‑associated protein 1  \n\n**Evidence**  \n- HSP7C_HUMAN (uniprot:P11142) – protein  \n- LPS‑associated protein 1 (synonym)  \n- 3.6.4.10 (synonym)  \n- Heat shock 70 kDa protein 8 (synonym)  \n- Heat shock cognate 71 kDa protein (synonym)  \n- LAP‑1 (synonym)  \n- Heat shock protein family A member 8 (synonym)  \n- Lipopolysaccharide‑associated protein 1 (synonym)",
  "context" : "[{\"proteinId\": \"uniprot.P11142\", \"proteinName\": \"HSP7C_HUMAN\", \"synonyms\": [\"LPS-associated protein 1\", \"3.6.4.10\", \"Heat shock 70 kDa protein 8\", \"Heat shock cognate 71 kDa protein\", \"LAP-1\", \"Heat shock protein family A member 8\", \"Lipopolysaccharide-associated protein 1\"]}]",
  "cypher" : "MATCH (p:Protein)\nWHERE toLower(p.displayName) = toLower('HSP7C_HUMAN')\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, p.synonyms AS synonyms;",
  "isCorrect" : true,
  "question" : "What are the synonyms for the protein HSP7C_HUMAN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \n\nNext steps: Try alternative names or synonyms for liver tissue, broaden the query to include other tissues, or relax the expression filter to capture additional drug targets.",
  "context" : "[{\"proteinId\": \"uniprot.P00734\", \"proteinName\": \"THRB_HUMAN\", \"drugId\": \"drugbank.DB00001\", \"drugName\": \"Lepirudin\"}, {\"proteinId\": \"uniprot.P00533\", \"proteinName\": \"EGFR_HUMAN\", \"drugId\": \"drugbank.DB00002\", \"drugName\": \"Cetuximab\"}, {\"proteinId\": \"uniprot.P31785\", \"proteinName\": \"IL2RG_HUMAN\", \"drugId\": \"drugbank.DB00004\", \"drugName\": \"Denileukin diftitox\"}, {\"proteinId\": \"uniprot.P14784\", \"proteinName\": \"IL2RB_HUMAN\", \"drugId\": \"drugbank.DB00004\", \"drugName\": \"Denileukin diftitox\"}, {\"proteinId\": \"uniprot.P01589\", \"proteinName\": \"IL2RA_HUMAN\", \"drugId\": \"drugbank.DB00004\", \"drugName\": \"Denileukin diftitox\"}, {\"proteinId\": \"uniprot.P01375\", \"proteinName\": \"TNFA_HUMAN\", \"drugId\": \"drugbank.DB00005\", \"drugName\": \"Etanercept\"}, {\"proteinId\": \"uniprot.P00734\", \"proteinName\": \"THRB_HUMAN\", \"drugId\": \"drugbank.DB00006\", \"drugName\": \"Bivalirudin\"}, {\"proteinId\": \"uniprot.P30968\", \"proteinName\": \"GNRHR_HUMAN\", \"drugId\": \"drugbank.DB00007\", \"drugName\": \"Leuprolide\"}, {\"proteinId\": \"uniprot.P17181\", \"proteinName\": \"INAR1_HUMAN\", \"drugId\": \"drugbank.DB00008\", \"drugName\": \"Peginterferon alfa-2a\"}, {\"proteinId\": \"uniprot.P00747\", \"proteinName\": \"PLMN_HUMAN\", \"drugId\": \"drugbank.DB00009\", \"drugName\": \"Alteplase\"}, {\"proteinId\": \"uniprot.P00747\", \"proteinName\": \"PLMN_HUMAN\", \"drugId\": \"drugbank.DB00013\", \"drugName\": \"Urokinase\"}, {\"proteinId\": \"uniprot.P30968\", \"proteinName\": \"GNRHR_HUMAN\", \"drugId\": \"drugbank.DB00014\", \"drugName\": \"Goserelin\"}, {\"proteinId\": \"uniprot.P00747\", \"proteinName\": \"PLMN_HUMAN\", \"drugId\": \"drugbank.DB00015\", \"drugName\": \"Reteplase\"}, {\"proteinId\": \"uniprot.Q99062\", \"proteinName\": \"CSF3R_HUMAN\", \"drugId\": \"drugbank.DB00019\", \"drugName\": \"Pegfilgrastim\"}, {\"proteinId\": \"uniprot.P17181\", \"proteinName\": \"INAR1_HUMAN\", \"drugId\": \"drugbank.DB00022\", \"drugName\": \"Peginterferon alfa-2b\"}, {\"proteinId\": \"uniprot.P16473\", \"proteinName\": \"TSHR_HUMAN\", \"drugId\": \"drugbank.DB00024\", \"drugName\": \"Thyrotropin alfa\"}, {\"proteinId\": \"uniprot.Q9NPH3\", \"proteinName\": \"IL1AP_HUMAN\", \"drugId\": \"drugbank.DB00026\", \"drugName\": \"Anakinra\"}, {\"proteinId\": \"uniprot.P14778\", \"proteinName\": \"IL1R1_HUMAN\", \"drugId\": \"drugbank.DB00026\", \"drugName\": \"Anakinra\"}, {\"proteinId\": \"uniprot.P33032\", \"proteinName\": \"MC5R_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P32245\", \"proteinName\": \"MC4R_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P24557\", \"proteinName\": \"THAS_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P06241\", \"proteinName\": \"FYN_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P06239\", \"proteinName\": \"LCK_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P25101\", \"proteinName\": \"EDNRA_HUMAN\", \"drugId\": \"drugbank.DB00027\", \"drugName\": \"Gramicidin D\"}, {\"proteinId\": \"uniprot.P06239\", \"proteinName\": \"LCK_HUMAN\", \"drugId\": \"drugbank.DB00030\", \"drugNa... (truncated)",
  "cypher" : "MATCH (d:Drug)-[:DrugHasTarget]->(p:Protein)-[:ProteinExpressedInTissue]->(t:Tissue)\nWHERE toLower(t.displayName) = 'liver'\nRETURN DISTINCT p.primaryDomainId AS proteinId, p.displayName AS proteinName, d.primaryDomainId AS drugId, d.displayName AS drugName;",
  "isCorrect" : true,
  "question" : "What are the known drug targets expressed in liver tissue?",
  "attempt" : 1,
  "fallback" : false
}, {
  "answer" : "**Answer**  \nThe graph returned a set of disorders that are associated with genes expressed in both kidney and liver tissues. These disorders include various cancers, metabolic syndromes, neuro‑ and hereditary diseases, and others listed below.\n\n**Evidence**  \n- Breast carcinoma (mondo.0004989)  \n- Cancer (mondo.0004992)  \n- Melanoma (mondo.0005105)  \n- Viral infectious disease (mondo.0005108)  \n- Infectious disease (mondo.0005550)  \n- Neurodegenerative disease (mondo.0005559)  \n- Hereditary disease (mondo.0003847)  \n- Gilbert syndrome (mondo.0007745)  \n- Crigler‑Najjar syndrome type 2 (mondo.0011725)  \n- Porphyrin metabolism disease (mondo.0037821)  \n- Bilirubin metabolism disease (mondo.0024431)  \n- Crigler‑Najjar syndrome type 1 (mondo.0021020)  \n- Crigler‑Najjar syndrome (mondo.0009044)  \n- Transient familial neonatal hyperbilirubinemia (mondo.0009383)  \n- Gallstones (mondo.0005346)  \n- Cholelithiasis (mondo.0012672)  \n- Vascular disorder (mondo.0005385)  \n- Attention‑deficit/hyperactivity disorder (mondo.0007743)  \n- Substance abuse (mondo.0002491)  \n- Renal osteodystrophy (mondo.0006946)  \n- Glioma (mondo.0021042)  \n- Breast lobular carcinoma (mondo.0000552)  \n- Mixed glioma (mondo.0003268)  \n- Squamous cell lung carcinoma (mondo.0005097)  \n- Skin basal cell carcinoma (mondo.0005341)  \n- Brain glioma (mondo.0005499)  \n- Breast ductal adenocarcinoma (mondo.0005590)  \n- Gastric adenoma (mondo.0006221)  \n- Invasive breast carcinoma (mondo.0006256)  \n- Giant cell glioblastoma (mondo.0016682)  \n- Anaplastic astrocytoma (mondo.0016684)  \n- Fibrillary astrocytoma (mondo.0016688)  \n- Diffuse large B‑cell lymphoma (mondo.0018905)  \n- Hypotrichosis 4 (mondo.0100522)  \n- Hyperaldosteronism (mondo.0003009)  \n- Alzheimer disease (mondo.0004975)  \n- Cervical carcinoma (mondo.0005131)  \n- Adolescent idiopathic scoliosis (mondo.0005488)  \n- Tremor, hereditary essential, 6 (mondo.0030027)  \n- Oculopharyngodistal myopathy (mondo.0025193)  \n- Neuronal intranuclear inclusion disease (mondo.0011327)  \n- Neu... (truncated)\n\n**Details**  \n\n| MONDO ID          | Disorder (display name)                               |\n|-------------------|--------------------------------------------------------|\n| mondo.0004989     | breast carcinoma                                       |\n| mondo.0004992     | cancer                                                 |\n| mondo.0005105     | melanoma                                               |\n| mondo.0005108     | viral infectious disease                               |\n| mondo.0005550     | infectious disease                                     |\n| mondo.0005559     | neurodegenerative disease                              |\n| mondo.0003847     | hereditary disease                                      |\n| mondo.0007745     | Gilbert syndrome                                       |\n| mondo.0011725     | Crigler‑Najjar syndrome type 2                         |\n| mondo.0037821     | porphyrin metabolism disease                           |\n| mondo.0024431     | bilirubin metabolism disease                           |\n| mondo.0021020     | Crigler‑Najjar syndrome type 1                         |\n| mondo.0009044     | Crigler‑Najjar syndrome                                 |\n| mondo.0009383     | transient familial neonatal hyperbilirubinemia         |\n| mondo.0005346     | gallstones                                             |\n| mondo.0012672     | cholelithiasis                                         |\n| mondo.0005385     | vascular disorder                                       |\n| mondo.0007743     | attention deficit‑hyperactivity disorder               |\n| mondo.0002491     | substance abuse                                         |\n| mondo.0006946     | renal osteodystrophy                                    |\n| mondo.0021042     | glioma                                                 |\n| mondo.0000552     | breast lobular carcinoma                               |\n| mondo.0003268     | mixed glioma                                            |\n| mondo.0005097     | squamous cell lung carcinoma                           |\n| mondo.0005341     | skin basal cell carcinoma                              |\n| mondo.0005499     | brain glioma                                            |\n| mondo.0005590     | breast ductal adenocarcinoma                           |\n| mondo.0006221     | gastric adenoma                                         |\n| mondo.0006256     | invasive breast carcinoma                              |\n| mondo.0016682     | giant cell glioblastoma                                 |\n| mondo.0016684     | anaplastic astrocytoma                                  |\n| mondo.0016688     | fibrillary astrocytoma                                  |\n| mondo.0018905     | diffuse large B‑cell lymphoma                          |\n| mondo.0100522     | hypotrichosis 4                                         |\n| mondo.0003009     | hyperaldosteronism                                       |\n| mondo.0004975     | Alzheimer disease                                       |\n| mondo.0005131     | cervical carcinoma                                      |\n| mondo.0005488     | adolescent idiopathic scoliosis                         |\n| mondo.0030027     | tremor, hereditary essential, 6                         |\n| mondo.0025193     | oculopharyngodistal myopathy                            |\n| mondo.0011327     | neuronal intranuclear inclusion disease                 |\n| mondo.0859207     | neu… (truncated)                                       |\n\nThese are the disorders recorded in the knowledge graph as linked to genes expressed in both kidney and liver tissues.",
  "context" : "[{\"disId\": \"mondo.0004989\", \"disDisplayName\": \"breast carcinoma\"}, {\"disId\": \"mondo.0004992\", \"disDisplayName\": \"cancer\"}, {\"disId\": \"mondo.0005105\", \"disDisplayName\": \"melanoma\"}, {\"disId\": \"mondo.0005108\", \"disDisplayName\": \"viral infectious disease\"}, {\"disId\": \"mondo.0005550\", \"disDisplayName\": \"infectious disease\"}, {\"disId\": \"mondo.0005559\", \"disDisplayName\": \"neurodegenerative disease\"}, {\"disId\": \"mondo.0003847\", \"disDisplayName\": \"hereditary disease\"}, {\"disId\": \"mondo.0007745\", \"disDisplayName\": \"Gilbert syndrome\"}, {\"disId\": \"mondo.0011725\", \"disDisplayName\": \"Crigler-Najjar syndrome type 2\"}, {\"disId\": \"mondo.0037821\", \"disDisplayName\": \"porphyrin metabolism disease\"}, {\"disId\": \"mondo.0024431\", \"disDisplayName\": \"bilirubin metabolism disease\"}, {\"disId\": \"mondo.0021020\", \"disDisplayName\": \"Crigler-Najjar syndrome type 1\"}, {\"disId\": \"mondo.0009044\", \"disDisplayName\": \"Crigler-Najjar syndrome\"}, {\"disId\": \"mondo.0009383\", \"disDisplayName\": \"transient familial neonatal hyperbilirubinemia\"}, {\"disId\": \"mondo.0005346\", \"disDisplayName\": \"gallstones\"}, {\"disId\": \"mondo.0012672\", \"disDisplayName\": \"cholelithiasis\"}, {\"disId\": \"mondo.0005385\", \"disDisplayName\": \"vascular disorder\"}, {\"disId\": \"mondo.0007743\", \"disDisplayName\": \"attention deficit-hyperactivity disorder\"}, {\"disId\": \"mondo.0002491\", \"disDisplayName\": \"substance abuse\"}, {\"disId\": \"mondo.0006946\", \"disDisplayName\": \"renal osteodystrophy\"}, {\"disId\": \"mondo.0021042\", \"disDisplayName\": \"glioma\"}, {\"disId\": \"mondo.0000552\", \"disDisplayName\": \"breast lobular carcinoma\"}, {\"disId\": \"mondo.0003268\", \"disDisplayName\": \"mixed glioma\"}, {\"disId\": \"mondo.0005097\", \"disDisplayName\": \"squamous cell lung carcinoma\"}, {\"disId\": \"mondo.0005341\", \"disDisplayName\": \"skin basal cell carcinoma\"}, {\"disId\": \"mondo.0005499\", \"disDisplayName\": \"brain glioma\"}, {\"disId\": \"mondo.0005590\", \"disDisplayName\": \"breast ductal adenocarcinoma\"}, {\"disId\": \"mondo.0006221\", \"disDisplayName\": \"gastric adenoma\"}, {\"disId\": \"mondo.0006256\", \"disDisplayName\": \"invasive breast carcinoma\"}, {\"disId\": \"mondo.0016682\", \"disDisplayName\": \"giant cell glioblastoma\"}, {\"disId\": \"mondo.0016684\", \"disDisplayName\": \"anaplastic astrocytoma\"}, {\"disId\": \"mondo.0016688\", \"disDisplayName\": \"fibrillary astrocytoma\"}, {\"disId\": \"mondo.0018905\", \"disDisplayName\": \"diffuse large B-cell lymphoma\"}, {\"disId\": \"mondo.0100522\", \"disDisplayName\": \"hypotrichosis 4\"}, {\"disId\": \"mondo.0003009\", \"disDisplayName\": \"hyperaldosteronism\"}, {\"disId\": \"mondo.0004975\", \"disDisplayName\": \"Alzheimer disease\"}, {\"disId\": \"mondo.0005131\", \"disDisplayName\": \"cervical carcinoma\"}, {\"disId\": \"mondo.0005488\", \"disDisplayName\": \"adolescent idiopathic scoliosis\"}, {\"disId\": \"mondo.0030027\", \"disDisplayName\": \"tremor, hereditary essential, 6\"}, {\"disId\": \"mondo.0025193\", \"disDisplayName\": \"oculopharyngodistal myopathy\"}, {\"disId\": \"mondo.0011327\", \"disDisplayName\": \"neuronal intranuclear inclusion disease\"}, {\"disId\": \"mondo.0859207\", \"disDisplayName\": \"neu... (truncated)",
  "cypher" : "MATCH (g:Gene)-[:GeneExpressedInTissue]->(tKidney:Tissue), (g)-[:GeneExpressedInTissue]->(tLiver:Tissue)\nWHERE toLower(tKidney.displayName) = toLower('kidney') AND toLower(tLiver.displayName) = toLower('liver')\nMATCH (g)-[r:GeneAssociatedWithDisorder]->(dis:Disorder)\nWHERE r.scoreOpenTargets IS NULL OR r.scoreOpenTargets > 0.3\nRETURN DISTINCT dis.primaryDomainId AS disId, dis.displayName AS disDisplayName;",
  "isCorrect" : false,
  "question" : "What are the common disorders associated with genes expressed in both kidney and liver tissues?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (t:Tissue {primaryDomainId:'uberon.0001003'})\nMATCH (g:Gene)-[:GeneExpressedInTissue]->(t)\nMATCH (g)-[r:GeneAssociatedWithDisorder]->(d:Disorder)\nWHERE (r.scoreOpenTargets IS NULL OR r.scoreOpenTargets > 0.3)\n  AND d.primaryDomainId IN ['mondo.0100118','mondo.0019268','mondo.0021154','mondo.0021026','mondo.0005093']\nMATCH (v:GenomicVariant)-[:VariantAssociatedWithDisorder]->(d)\nRETURN v.primaryDomainId AS variantId, v.displayName AS variantName,\n       d.primaryDomainId AS disorderId, d.displayName AS disorderName,\n       g.primaryDomainId AS geneId, g.displayName AS geneName;",
  "isCorrect" : true,
  "question" : "What are the genomic variants associated with disorders that affect gene expression in the skin epidermis?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nDrugs that target proteins expressed in the stomach are associated with a range of adverse events.  The most common side effects reported in the graph include sleep‑related disturbances (e.g., insomnia), gastrointestinal signs such as increased amylase, elevated blood glucose and abdominal pain, appetite suppression (hyporexia, decreased appetite), and musculoskeletal complaints (muscle pain, myalgia).  Other notable effects involve liver‑enzyme elevations and skin dryness.\n\n**Evidence:**  \n- Sleeplessness (meddra.10041017)  \n- Insomnia disorder (meddra.10078083)  \n- Insomnia NOS (meddra.10022442)  \n- Insomnia (meddra.10022437)  \n- Amylase increased (meddra.10002016)  \n- Amylase high (meddra.10002015)  \n- Blood amylase increased (meddra.10005328)  \n- Blood sugar increased (meddra.10005809)  \n- Blood glucose increased (meddra.10005557)  \n- Glucose blood increased (meddra.10018418)  \n- Sugar blood increased (meddra.10042446)  \n- Sugar blood level increased (meddra.10042448)  \n- Lipase increased (meddra.10024574)  \n- Upper abdominal pain (meddra.10046272)  \n- Abdominal pain upper (meddra.10000087)  \n- Hyporexia (meddra.10067342)  \n- Appetite decreased NOS (meddra.10003020)  \n- Inappetence (meddra.10054792)  \n- Decreased appetite (meddra.10061428)  \n- Pain muscle (meddra.10033466)  \n- Muscle ache (meddra.10028287)  \n- Muscle discomfort (meddra.10028299)  \n- Muscular pain (meddra.10028361)  \n- Muscle pain (meddra.10028322)  \n- Muscular pains (meddra.10028362)  \n- Generalised muscle aches (meddra.10018089)  \n- Muscle soreness (meddra.10028332)  \n- Myalgia (meddra.10028411)  \n- Generalized muscle aches (meddra.10062441)  \n- Muscle pains (meddra.10028323)  \n- Pituitary‑dependent Cushing's syndrome (meddra.10035109)  \n- Cushing's disease (meddra.10011651)  \n- Skin dry (meddra.10040835)  \n- Dry skin (meddra.10013786)  \n- Glutamic‑pyruvate transaminase increased (meddra.10018455)  \n- Serum glutamic‑pyruvic ta increased (meddra.10056502)  \n- Alanine aminotransferase increase (meddra.10001550)  \n- Serum glutamic‑pyruvic transaminase increased (meddra.10040275)\n\n*(Additional side‑effect entries were truncated in the supplied result.)*",
  "context" : "[{\"sideEffectId\": \"meddra.10041017\", \"sideEffectName\": \"Sleeplessness\"}, {\"sideEffectId\": \"meddra.10078083\", \"sideEffectName\": \"Insomnia disorder\"}, {\"sideEffectId\": \"meddra.10022442\", \"sideEffectName\": \"Insomnia NOS\"}, {\"sideEffectId\": \"meddra.10022437\", \"sideEffectName\": \"Insomnia\"}, {\"sideEffectId\": \"meddra.10002016\", \"sideEffectName\": \"Amylase increased\"}, {\"sideEffectId\": \"meddra.10002015\", \"sideEffectName\": \"Amylase high\"}, {\"sideEffectId\": \"meddra.10005328\", \"sideEffectName\": \"Blood amylase increased\"}, {\"sideEffectId\": \"meddra.10005809\", \"sideEffectName\": \"Blood sugar increased\"}, {\"sideEffectId\": \"meddra.10005557\", \"sideEffectName\": \"Blood glucose increased\"}, {\"sideEffectId\": \"meddra.10018418\", \"sideEffectName\": \"Glucose blood increased\"}, {\"sideEffectId\": \"meddra.10042446\", \"sideEffectName\": \"Sugar blood increased\"}, {\"sideEffectId\": \"meddra.10042448\", \"sideEffectName\": \"Sugar blood level increased\"}, {\"sideEffectId\": \"meddra.10024574\", \"sideEffectName\": \"Lipase increased\"}, {\"sideEffectId\": \"meddra.10046272\", \"sideEffectName\": \"Upper abdominal pain\"}, {\"sideEffectId\": \"meddra.10000087\", \"sideEffectName\": \"Abdominal pain upper\"}, {\"sideEffectId\": \"meddra.10067342\", \"sideEffectName\": \"Hyporexia\"}, {\"sideEffectId\": \"meddra.10003020\", \"sideEffectName\": \"Appetite decreased NOS\"}, {\"sideEffectId\": \"meddra.10054792\", \"sideEffectName\": \"Inappetence\"}, {\"sideEffectId\": \"meddra.10061428\", \"sideEffectName\": \"Decreased appetite\"}, {\"sideEffectId\": \"meddra.10033466\", \"sideEffectName\": \"Pain muscle\"}, {\"sideEffectId\": \"meddra.10028287\", \"sideEffectName\": \"Muscle ache\"}, {\"sideEffectId\": \"meddra.10028299\", \"sideEffectName\": \"Muscle discomfort\"}, {\"sideEffectId\": \"meddra.10028361\", \"sideEffectName\": \"Muscular pain\"}, {\"sideEffectId\": \"meddra.10028322\", \"sideEffectName\": \"Muscle pain\"}, {\"sideEffectId\": \"meddra.10028362\", \"sideEffectName\": \"Muscular pains\"}, {\"sideEffectId\": \"meddra.10018089\", \"sideEffectName\": \"Generalised muscle aches\"}, {\"sideEffectId\": \"meddra.10028332\", \"sideEffectName\": \"Muscle soreness\"}, {\"sideEffectId\": \"meddra.10028411\", \"sideEffectName\": \"Myalgia\"}, {\"sideEffectId\": \"meddra.10062441\", \"sideEffectName\": \"Generalized muscle aches\"}, {\"sideEffectId\": \"meddra.10028323\", \"sideEffectName\": \"Muscle pains\"}, {\"sideEffectId\": \"meddra.10035109\", \"sideEffectName\": \"Pituitary-dependent Cushing's syndrome\"}, {\"sideEffectId\": \"meddra.10011651\", \"sideEffectName\": \"Cushing's disease\"}, {\"sideEffectId\": \"meddra.10040835\", \"sideEffectName\": \"Skin dry\"}, {\"sideEffectId\": \"meddra.10013786\", \"sideEffectName\": \"Dry skin\"}, {\"sideEffectId\": \"meddra.10018455\", \"sideEffectName\": \"Glutamic-pyruvate transaminase increased\"}, {\"sideEffectId\": \"meddra.10056502\", \"sideEffectName\": \"Serum glutamic-pyruvic ta increased\"}, {\"sideEffectId\": \"meddra.10001550\", \"sideEffectName\": \"Alanine aminotransferase increase\"}, {\"sideEffectId\": \"meddra.10040275\", \"sideEffectName\": \"Serum glutamic-pyruvic transaminase increased\"}, {\"sideEffectId\": \"meddra.10018457\", \"side... (truncated)",
  "cypher" : "MATCH (t:Tissue {primaryDomainId:'uberon.0000945'})\nMATCH (p:Protein)-[:ProteinExpressedInTissue]->(t)\nMATCH (d:Drug)-[:DrugHasTarget]->(p)\nMATCH (d)-[:DrugHasSideEffect]->(s:SideEffect)\nRETURN DISTINCT s.primaryDomainId AS sideEffectId, s.displayName AS sideEffectName",
  "isCorrect" : false,
  "question" : "What are the side effects of drugs that target proteins expressed in the stomach?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (go:GO)\nWHERE go.primaryDomainId IN ['go.0016064','go.0002251','go.0002437','go.0050776','go.0090716']\nMATCH (p:Protein)-[:ProteinHasGOAnnotation]->(go)\nMATCH (g:Gene)-[:ProteinEncodedByGene]->(p)\nMATCH (g)-[:GeneExpressedInTissue]->(t:Tissue)\nRETURN DISTINCT t.primaryDomainId AS tissueId, t.displayName AS tissueName",
  "isCorrect" : true,
  "question" : "Which tissues express genes related to the GO term 'immune response'?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for the gene, broaden the query to include related tissues, or relax any filters that may have limited the search.",
  "context" : "[]",
  "cypher" : "MATCH (g:Gene)-[:ProteinEncodedByGene]->(p:Protein)-[:ProteinExpressedInTissue]->(t:Tissue)\nWHERE toLower(g.displayName) = toLower('TTN')\nRETURN DISTINCT t.primaryDomainId AS tissueId, t.displayName AS tissue",
  "isCorrect" : true,
  "question" : "Which tissues express the gene TTN?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe gene MSH2 is approved under the symbol **MSH2**. In the graph it has the following synonyms:  \n- DNA mismatch repair protein Msh2  \n- DNA mismatch repair protein Msh2 transcript  \n- MutS‑like 2  \n- mutS homolog 2, colon cancer, nonpolyposis type 1  \n- mutS homolog 2  \n\n**Evidence:**  \n- MSH2 () – approved symbol  \n\n**Details (optional):**  \n| Approved Symbol | Synonyms (list) |\n|-----------------|----------------|\n| MSH2 | [\"DNA mismatch repair protein Msh2\", \"DNA mismatch repair protein Msh2 transcript\", \"MutS‑like 2\", \"mutS homolog 2, colon cancer, nonpolyposis type 1\", \"mutS homolog 2\"] |\n",
  "context" : "[{\"geneId\": \"entrez.4436\", \"geneName\": \"MSH2\", \"approvedSymbol\": \"MSH2\", \"synonyms\": [\"DNA mismatch repair protein Msh2\", \"DNA mismatch repair protein Msh2 transcript\", \"MutS-like 2\", \"mutS homolog 2, colon cancer, nonpolyposis type 1\", \"mutS homolog 2\"]}]",
  "cypher" : "MATCH (g:Gene)\nWHERE toLower(g.displayName) = toLower('MSH2')\nRETURN g.primaryDomainId AS geneId,\n       g.displayName AS geneName,\n       g.approvedSymbol AS approvedSymbol,\n       g.synonyms AS synonyms;",
  "isCorrect" : true,
  "question" : "What are the approved symbols and synonyms for the gene MSH2?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (g:Gene) WHERE toLower(g.displayName) = 'cftr'\nMATCH (p:Protein)-[:ProteinEncodedByGene]->(g)\nWHERE p.primaryDomainId IN ['uniprot.A0A088T1A1','uniprot.A0A8V8TNN7','uniprot.Q6KEH9','uniprot.O00717','uniprot.Q5I6N7']\nMATCH (p)-[:ProteinInPathway]->(pw:Pathway)\nRETURN pw.primaryDomainId AS pathwayId, pw.displayName AS pathwayName",
  "isCorrect" : true,
  "question" : "What are the pathways associated with proteins encoded by the gene CFTR?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe BRCA2 gene is expressed in a wide variety of human tissues, including reproductive, digestive, respiratory, endocrine, musculoskeletal, and nervous system tissues.  \nKey tissues with documented BRCA2 expression are:  \n\n- Vagina, urinary bladder, tonsil, tongue, thyroid gland, thymus, testis, stomach, spleen, spinal cord, smooth‑muscle tissue, small intestine, skin epidermis, zone of skin, skeletal muscle tissue, seminal vesicle, saliva‑secreting gland, retina, rectum, prostate gland, placenta, pituitary gland, parathyroid gland, pancreas, ovary, midbrain, lymph node, lung, liver, kidney, hypothalamus, hippocampal formation, cardiac muscle tissue, heart, gall bladder, fallopian tube, esophagus, epididymis, endometrium, duodenum, colon, choroid plexus, uterine cervix, cerebral cortex, cerebellum, mammary gland, breast, bone marrow, and nucleus accumbens.\n\n**Evidence:**\n- Vagina (uberon.0000996)  \n- Urinary bladder (uberon.0001255)  \n- Tonsil (uberon.0002372)  \n- Tongue (uberon.0001723)  \n- Thyroid gland (uberon.0002046)  \n- Thymus (uberon.0002370)  \n- Testis (uberon.0000473)  \n- Stomach (uberon.0000945)  \n- Spleen (uberon.0002106)  \n- Spinal cord (uberon.0002240)  \n- Smooth muscle tissue (uberon.0001135)  \n- Small intestine (uberon.0002108)  \n- Skin epidermis (uberon.0001003)  \n- Zone of skin (uberon.0000014)  \n- Skeletal muscle tissue (uberon.0001134)  \n- Seminal vesicle (uberon.0000998)  \n- Saliva‑secreting gland (uberon.0001044)  \n- Retina (uberon.0000966)  \n- Rectum (uberon.0001052)  \n- Prostate gland (uberon.0002367)  \n- Placenta (uberon.0001987)  \n- Pituitary gland (uberon.0000007)  \n- Parathyroid gland (uberon.0001132)  \n- Pancreas (uberon.0001264)  \n- Ovary (uberon.0000992)  \n- Midbrain (uberon.0001891)  \n- Lymph node (uberon.0000029)  \n- Lung (uberon.0002048)  \n- Liver (uberon.0002107)  \n- Kidney (uberon.0002113)  \n- Hypothalamus (uberon.0001898)  \n- Hippocampal formation (uberon.0002421)  \n- Cardiac muscle tissue (uberon.0001133)  \n- Heart (uberon.0000948)  \n- Gall bladder (uberon.0002110)  \n- Fallopian tube (uberon.0003889)  \n- Esophagus (uberon.0001043)  \n- Epididymis (uberon.0001301)  \n- Endometrium (uberon.0001295)  \n- Duodenum (uberon.0002114)  \n- Colon (uberon.0001155)  \n- Choroid plexus (uberon.0001886)  \n- Uterine cervix (uberon.0000002)  \n- Cerebral cortex (uberon.0000956)  \n- Cerebellum (uberon.0002037)  \n- Mammary gland (uberon.0001911)  \n- Breast (uberon.0000310)  \n- Bone marrow (uberon.0002371)  \n- Nucleus accumbens (uberon.0001882)  \n\n**Details (table)**  \n\n| Tissue Name | Tissue ID |\n|-------------|-----------|\n| Vagina | uberon.0000996 |\n| Urinary bladder | uberon.0001255 |\n| Tonsil | uberon.0002372 |\n| Tongue | uberon.0001723 |\n| Thyroid gland | uberon.0002046 |\n| Thymus | uberon.0002370 |\n| Testis | uberon.0000473 |\n| Stomach | uberon.0000945 |\n| Spleen | uberon.0002106 |\n| Spinal cord | uberon.0002240 |\n| Smooth muscle tissue | uberon.0001135 |\n| Small intestine | uberon.0002108 |\n| Skin epidermis | uberon.0001003 |\n| Zone of skin | uberon.0000014 |\n| Skeletal muscle tissue | uberon.0001134 |\n| Seminal vesicle | uberon.0000998 |\n| Saliva‑secreting gland | uberon.0001044 |\n| Retina | uberon.0000966 |\n| Rectum | uberon.0001052 |\n| Prostate gland | uberon.0002367 |\n| Placenta | uberon.0001987 |\n| Pituitary gland | uberon.0000007 |\n| Parathyroid gland | uberon.0001132 |\n| Pancreas | uberon.0001264 |\n| Ovary | uberon.0000992 |\n| Midbrain | uberon.0001891 |\n| Lymph node | uberon.0000029 |\n| Lung | uberon.0002048 |\n| Liver | uberon.0002107 |\n| Kidney | uberon.0002113 |\n| Hypothalamus | uberon.0001898 |\n| Hippocampal formation | uberon.0002421 |\n| Cardiac muscle tissue | uberon.0001133 |\n| Heart | uberon.0000948 |\n| Gall bladder | uberon.0002110 |\n| Fallopian tube | uberon.0003889 |\n| Esophagus | uberon.0001043 |\n| Epididymis | uberon.0001301 |\n| Endometrium | uberon.0001295 |\n| Duodenum | uberon.0002114 |\n| Colon | uberon.0001155 |\n| Choroid plexus | uberon.0001886 |\n| Uterine cervix | uberon.0000002 |\n| Cerebral cortex | uberon.0000956 |\n| Cerebellum | uberon.0002037 |\n| Mammary gland | uberon.0001911 |\n| Breast | uberon.0000310 |\n| Bone marrow | uberon.0002371 |\n| Nucleus accumbens | uberon.0001882 |",
  "context" : "[{\"tissueId\": \"uberon.0000996\", \"tissueName\": \"vagina\"}, {\"tissueId\": \"uberon.0001255\", \"tissueName\": \"urinary bladder\"}, {\"tissueId\": \"uberon.0002372\", \"tissueName\": \"tonsil\"}, {\"tissueId\": \"uberon.0001723\", \"tissueName\": \"tongue\"}, {\"tissueId\": \"uberon.0002046\", \"tissueName\": \"thyroid gland\"}, {\"tissueId\": \"uberon.0002370\", \"tissueName\": \"thymus\"}, {\"tissueId\": \"uberon.0000473\", \"tissueName\": \"testis\"}, {\"tissueId\": \"uberon.0000945\", \"tissueName\": \"stomach\"}, {\"tissueId\": \"uberon.0002106\", \"tissueName\": \"spleen\"}, {\"tissueId\": \"uberon.0002240\", \"tissueName\": \"spinal cord\"}, {\"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"tissueId\": \"uberon.0002108\", \"tissueName\": \"small intestine\"}, {\"tissueId\": \"uberon.0001003\", \"tissueName\": \"skin epidermis\"}, {\"tissueId\": \"uberon.0000014\", \"tissueName\": \"zone of skin\"}, {\"tissueId\": \"uberon.0001134\", \"tissueName\": \"skeletal muscle tissue\"}, {\"tissueId\": \"uberon.0000998\", \"tissueName\": \"seminal vesicle\"}, {\"tissueId\": \"uberon.0001044\", \"tissueName\": \"saliva-secreting gland\"}, {\"tissueId\": \"uberon.0000966\", \"tissueName\": \"retina\"}, {\"tissueId\": \"uberon.0001052\", \"tissueName\": \"rectum\"}, {\"tissueId\": \"uberon.0002367\", \"tissueName\": \"prostate gland\"}, {\"tissueId\": \"uberon.0001987\", \"tissueName\": \"placenta\"}, {\"tissueId\": \"uberon.0000007\", \"tissueName\": \"pituitary gland\"}, {\"tissueId\": \"uberon.0001132\", \"tissueName\": \"parathyroid gland\"}, {\"tissueId\": \"uberon.0001264\", \"tissueName\": \"pancreas\"}, {\"tissueId\": \"uberon.0000992\", \"tissueName\": \"ovary\"}, {\"tissueId\": \"uberon.0001891\", \"tissueName\": \"midbrain\"}, {\"tissueId\": \"uberon.0000029\", \"tissueName\": \"lymph node\"}, {\"tissueId\": \"uberon.0002048\", \"tissueName\": \"lung\"}, {\"tissueId\": \"uberon.0002107\", \"tissueName\": \"liver\"}, {\"tissueId\": \"uberon.0002113\", \"tissueName\": \"kidney\"}, {\"tissueId\": \"uberon.0001898\", \"tissueName\": \"hypothalamus\"}, {\"tissueId\": \"uberon.0002421\", \"tissueName\": \"hippocampal formation\"}, {\"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"tissueId\": \"uberon.0000948\", \"tissueName\": \"heart\"}, {\"tissueId\": \"uberon.0002110\", \"tissueName\": \"gall bladder\"}, {\"tissueId\": \"uberon.0003889\", \"tissueName\": \"fallopian tube\"}, {\"tissueId\": \"uberon.0001043\", \"tissueName\": \"esophagus\"}, {\"tissueId\": \"uberon.0001301\", \"tissueName\": \"epididymis\"}, {\"tissueId\": \"uberon.0001295\", \"tissueName\": \"endometrium\"}, {\"tissueId\": \"uberon.0002114\", \"tissueName\": \"duodenum\"}, {\"tissueId\": \"uberon.0001155\", \"tissueName\": \"colon\"}, {\"tissueId\": \"uberon.0001886\", \"tissueName\": \"choroid plexus\"}, {\"tissueId\": \"uberon.0000002\", \"tissueName\": \"uterine cervix\"}, {\"tissueId\": \"uberon.0000956\", \"tissueName\": \"cerebral cortex\"}, {\"tissueId\": \"uberon.0002037\", \"tissueName\": \"cerebellum\"}, {\"tissueId\": \"uberon.0001911\", \"tissueName\": \"mammary gland\"}, {\"tissueId\": \"uberon.0000310\", \"tissueName\": \"breast\"}, {\"tissueId\": \"uberon.0002371\", \"tissueName\": \"bone marrow\"}, {\"tissueId\": \"uberon.0001882\", \"tissueName\": \"nucleus accumbens\"}, {\"tissu... (truncated)",
  "cypher" : "MATCH (g:Gene)-[r]->(t:Tissue)\nWHERE toLower(g.displayName) = toLower('BRCA2')\nRETURN t.primaryDomainId AS tissueId, t.displayName AS tissueName;",
  "isCorrect" : false,
  "question" : "Which tissues express the BRCA2 gene?",
  "attempt" : 1,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe APC gene is a **protein‑coding** gene. Its product functions as a **regulator of the Wnt signaling pathway**.\n\n**Evidence:**  \n- **APC (entrez.324)** – gene type: protein‑coding; description: APC regulator of Wnt signaling pathway.\n\n**Details (optional table):**\n\n| Gene ID        | Gene Name | Gene Type   | Description                         |\n|----------------|-----------|-------------|-------------------------------------|\n| entrez.324     | APC       | protein‑coding | APC regulator of Wnt signaling pathway |",
  "context" : "[{\"geneId\": \"entrez.324\", \"geneName\": \"APC\", \"geneType\": \"protein-coding\", \"description\": \"APC regulator of Wnt signaling pathway\"}]",
  "cypher" : "MATCH (g:Gene)\nWHERE toLower(g.displayName) = toLower('APC')\nRETURN g.primaryDomainId AS geneId, g.displayName AS geneName, g.geneType AS geneType, g.description AS description;",
  "isCorrect" : true,
  "question" : "Provide the gene type and description for the APC gene.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe BRCA1 gene encodes 22 distinct protein products in the graph, including the canonical BRCA1 protein (UniProt P38398). The other entries represent alternative splice variants or uncharacterized proteins associated with BRCA1.\n\n**Evidence:**  \n- BRCA1_HUMAN (UniProt P38398) – canonical protein  \n- C9IZW4_HUMAN (UniProt C9IZW4) – variant protein  \n- A0A9Y1QQK7_HUMAN (UniProt A0A9Y1QQK7) – variant protein  \n- A0A9Y1QQK3_HUMAN (UniProt A0A9Y1QQK3) – variant protein  \n- A0A9Y1QPR4_HUMAN (UniProt A0A9Y1QPR4) – variant protein  \n- A0A9Y1QQ47_HUMAN (UniProt A0A9Y1QQ47) – variant protein  \n- A0A9Y1QQD3_HUMAN (UniProt A0A9Y1QQD3) – variant protein  \n- A0A0U1RRA9_HUMAN (UniProt A0A0U1RRA9) – variant protein  \n- H0Y850_HUMAN (UniProt H0Y850) – variant protein  \n- A0A9Y1QQF1_HUMAN (UniProt A0A9Y1QQF1) – variant protein  \n- A0A9Y1VVD0_HUMAN (UniProt A0A9Y1VVD0) – variant protein  \n- E7EUM2_HUMAN (UniProt E7EUM2) – variant protein  \n- A0A9Y1QPY6_HUMAN (UniProt A0A9Y1QPY6) – variant protein  \n- A0A9Y1VR53_HUMAN (UniProt A0A9Y1VR53) – variant protein  \n- H0Y8D8_HUMAN (UniProt H0Y8D8) – variant protein  \n- A0A9Y1QQJ6_HUMAN (UniProt A0A9Y1QQJ6) – variant protein  \n- A0A2R8Y7V5_HUMAN (UniProt A0A2R8Y7V5) – variant protein  \n- E7EQW4_HUMAN (UniProt E7EQW4) – variant protein  \n- E7ENB7_HUMAN (UniProt E7ENB7) – variant protein  \n- B4DES0_HUMAN (UniProt B4DES0) – variant protein  \n- A0A9Y1QPT7_HUMAN (UniProt A0A9Y1QPT7) – variant protein  \n- A0A9Y1VVE2_HUMAN (UniProt A0A9Y1VVE2) – variant protein  \n\n**Details (protein list):**\n\n| Protein name           | UniProt ID |\n|------------------------|------------|\n| BRCA1_HUMAN            | P38398     |\n| C9IZW4_HUMAN           | C9IZW4     |\n| A0A9Y1QQK7_HUMAN       | A0A9Y1QQK7 |\n| A0A9Y1QQK3_HUMAN       | A0A9Y1QQK3 |\n| A0A9Y1QPR4_HUMAN       | A0A9Y1QPR4 |\n| A0A9Y1QQ47_HUMAN       | A0A9Y1QQ47 |\n| A0A9Y1QQD3_HUMAN       | A0A9Y1QQD3 |\n| A0A0U1RRA9_HUMAN       | A0A0U1RRA9 |\n| H0Y850_HUMAN           | H0Y850     |\n| A0A9Y1QQF1_HUMAN       | A0A9Y1QQF1 |\n| A0A9Y1VVD0_HUMAN       | A0A9Y1VVD0 |\n| E7EUM2_HUMAN           | E7EUM2     |\n| A0A9Y1QPY6_HUMAN       | A0A9Y1QPY6 |\n| A0A9Y1VR53_HUMAN       | A0A9Y1VR53 |\n| H0Y8D8_HUMAN           | H0Y8D8     |\n| A0A9Y1QQJ6_HUMAN       | A0A9Y1QQJ6 |\n| A0A2R8Y7V5_HUMAN       | A0A2R8Y7V5 |\n| E7EQW4_HUMAN           | E7EQW4     |\n| E7ENB7_HUMAN           | E7ENB7     |\n| B4DES0_HUMAN           | B4DES0     |\n| A0A9Y1QPT7_HUMAN       | A0A9Y1QPT7 |\n| A0A9Y1VVE2_HUMAN       | A0A9Y1VVE2 |\n\nThese entries represent all protein nodes linked to the BRCA1 gene in the knowledge graph.",
  "context" : "[{\"proteinId\": \"uniprot.C9IZW4\", \"proteinName\": \"C9IZW4_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQK7\", \"proteinName\": \"A0A9Y1QQK7_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQK3\", \"proteinName\": \"A0A9Y1QQK3_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QPR4\", \"proteinName\": \"A0A9Y1QPR4_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQ47\", \"proteinName\": \"A0A9Y1QQ47_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQD3\", \"proteinName\": \"A0A9Y1QQD3_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A0U1RRA9\", \"proteinName\": \"A0A0U1RRA9_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.H0Y850\", \"proteinName\": \"H0Y850_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQF1\", \"proteinName\": \"A0A9Y1QQF1_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1VVD0\", \"proteinName\": \"A0A9Y1VVD0_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.E7EUM2\", \"proteinName\": \"E7EUM2_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QPY6\", \"proteinName\": \"A0A9Y1QPY6_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1VR53\", \"proteinName\": \"A0A9Y1VR53_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.H0Y8D8\", \"proteinName\": \"H0Y8D8_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QQJ6\", \"proteinName\": \"A0A9Y1QQJ6_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A2R8Y7V5\", \"proteinName\": \"A0A2R8Y7V5_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.E7EQW4\", \"proteinName\": \"E7EQW4_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.E7ENB7\", \"proteinName\": \"E7ENB7_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.B4DES0\", \"proteinName\": \"B4DES0_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1QPT7\", \"proteinName\": \"A0A9Y1QPT7_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.P38398\", \"proteinName\": \"BRCA1_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}, {\"proteinId\": \"uniprot.A0A9Y1VVE2\", \"proteinName\": \"A0A9Y1VVE2_HUMAN\", \"geneId\": \"entrez.672\", \"geneName\": \"BRCA1\"}]",
  "cypher" : "MATCH (g:Gene {primaryDomainId:'entrez.672'})\nMATCH (p:Protein)-[:ProteinEncodedByGene]->(g)\nRETURN p.primaryDomainId AS proteinId, p.displayName AS proteinName, g.primaryDomainId AS geneId, g.displayName AS geneName",
  "isCorrect" : true,
  "question" : "What proteins are encoded by the BRCA1 gene?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe protein encoded by TSC2, TSC2_HUMAN (UniProt P49815), is annotated with a range of Gene Ontology (GO) terms. Key GO categories include regulation of cell cycle, negative regulation of insulin‑receptor signaling, negative regulation of Wnt signaling, the TSC1‑TSC2 complex, perinuclear cytoplasm localization, synaptic and membrane associations, cytosolic and lysosomal localization, postsynaptic density, regulation of TORC1 signaling, mitophagy, PI3K/AKT signaling, small GTPase‑mediated signal transduction, and chemotaxis.  \n\n**Evidence:**  \n- TSC2_HUMAN (uniprot.P49815) – protein encoded by TSC2 (entrez.7249)  \n- GO:0051726 – regulation of cell cycle  \n- GO:0046627 – negative regulation of insulin receptor signaling pathway  \n- GO:0030178 – negative regulation of Wnt signaling pathway  \n- GO:0033596 – TSC1‑TSC2 complex  \n- GO:0048471 – perinuclear region of cytoplasm  \n- GO:0045202 – synapse  \n- GO:0016020 – membrane  \n- GO:0005829 – cytosol  \n- GO:0005764 – lysosome  \n- GO:0014069 – postsynaptic density  \n- GO:0005765 – lysosomal membrane  \n- GO:1904262 – negative regulation of TORC1 signaling  \n- GO:1901525 – negative regulation of mitophagy  \n- GO:0051898 – negative regulation of phosphatidylinositol 3‑kinase/protein kinase B signal transduction  \n- GO:0051056 – regulation of small GTPase mediated signal transduction  \n- GO:0050918 – positive chemotaxis  \n- GO:0046626 – regulation of insulin receptor signaling pathway  \n\n**Details (selected)**  \n\n| GO ID     | GO Name                                                                 |\n|-----------|--------------------------------------------------------------------------|\n| GO:0051726 | regulation of cell cycle                                               |\n| GO:0046627 | negative regulation of insulin receptor signaling pathway             |\n| GO:0030178 | negative regulation of Wnt signaling pathway                           |\n| GO:0033596 | TSC1‑TSC2 complex                                                      |\n| GO:0048471 | perinuclear region of cytoplasm                                        |\n| GO:0045202 | synapse                                                                |\n| GO:0016020 | membrane                                                               |\n| GO:0005829 | cytosol                                                                |\n| GO:0005764 | lysosome                                                               |\n| GO:0014069 | postsynaptic density                                                   |\n| GO:0005765 | lysosomal membrane                                                     |\n| GO:1904262 | negative regulation of TORC1 signaling                                |\n| GO:1901525 | negative regulation of mitophagy                                       |\n| GO:0051898 | negative regulation of PI3K/AKT signal transduction                    |\n| GO:0051056 | regulation of small GTPase mediated signal transduction                |\n| GO:0050918 | positive chemotaxis                                                     |\n| GO:0046626 | regulation of insulin receptor signaling pathway                       |",
  "context" : "[{\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0051726\", \"goName\": \"regulation of cell cycle\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0046627\", \"goName\": \"negative regulation of insulin receptor signaling pathway\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0030178\", \"goName\": \"negative regulation of Wnt signaling pathway\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0033596\", \"goName\": \"TSC1-TSC2 complex\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0048471\", \"goName\": \"perinuclear region of cytoplasm\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0045202\", \"goName\": \"synapse\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0016020\", \"goName\": \"membrane\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0005829\", \"goName\": \"cytosol\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0005764\", \"goName\": \"lysosome\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0014069\", \"goName\": \"postsynaptic density\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0005765\", \"goName\": \"lysosomal membrane\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.1904262\", \"goName\": \"negative regulation of TORC1 signaling\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.1901525\", \"goName\": \"negative regulation of mitophagy\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0051898\", \"goName\": \"negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0051056\", \"goName\": \"regulation of small GTPase mediated signal transduction\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0050918\", \"goName\": \"positive chemotaxis\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", \"proteinId\": \"uniprot.P49815\", \"proteinName\": \"TSC2_HUMAN\", \"goId\": \"go.0046626\", \"goName\": \"regulation of insulin receptor signaling pathway\"}, {\"geneId\": \"entrez.7249\", \"geneName\": \"TSC2\", ... (truncated)",
  "cypher" : "MATCH (g:Gene {primaryDomainId:'entrez.7249'})\nMATCH (p:Protein)-[:ProteinEncodedByGene]->(g)\nMATCH (p)-[:ProteinHasGOAnnotation]->(go:GO)\nRETURN g.primaryDomainId AS geneId,\n       g.displayName AS geneName,\n       p.primaryDomainId AS proteinId,\n       p.displayName AS proteinName,\n       go.primaryDomainId AS goId,\n       go.displayName AS goName;",
  "isCorrect" : false,
  "question" : "What are the GO annotations for proteins encoded by the TSC2 gene?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nMSH6 is expressed in adipose tissue, and several other genes are also expressed in this tissue.  \nAmong the genes co‑expressed in adipose tissue are PYDC5, CTAGE8, PPIAL4D, RPSA2, and PPIAL4C (plus many others).\n\n**Evidence**  \n- **PYDC5** (entrez.107181291) – expressed in adipose tissue  \n- **CTAGE8** (entrez.100142659) – expressed in adipose tissue  \n- **PPIAL4D** (entrez.645142) – expressed in adipose tissue  \n- **RPSA2** (entrez.388524) – expressed in adipose tissue  \n- **PPIAL4C** (entrez.653598) – expressed in adipose tissue  \n\n**Details (partial list)**  \n\n| Gene (displayName) | Gene ID | Tissue (displayName) | Tissue ID |\n|--------------------|---------|----------------------|-----------|\n| PYDC5 | entrez.107181291 | adipose tissue | uberon.0001013 |\n| CTAGE8 | entrez.100142659 | adipose tissue | uberon.0001013 |\n| PPIAL4D | entrez.645142 | adipose tissue | uberon.0001013 |\n| RPSA2 | entrez.388524 | adipose tissue | uberon.0001013 |\n| PPIAL4C | entrez.653598 | adipose tissue | uberon.0001013 |",
  "context" : "[{\"geneId\": \"entrez.107181291\", \"geneName\": \"PYDC5\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.100142659\", \"geneName\": \"CTAGE8\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.645142\", \"geneName\": \"PPIAL4D\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.388524\", \"geneName\": \"RPSA2\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.653598\", \"geneName\": \"PPIAL4C\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.114118903\", \"geneName\": \"ARHGAP11A-SCG5\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.723790\", \"geneName\": \"H2AC19\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.8337\", \"geneName\": \"H2AC18\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.100128553\", \"geneName\": \"CTAGE4\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.8263\", \"geneName\": \"F8A1\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.474383\", \"geneName\": \"F8A2\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.54579\", \"geneName\": \"UGT1A5\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.54659\", \"geneName\": \"UGT1A3\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.114841037\", \"geneName\": \"CIMIP3\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.8352\", \"geneName\": \"H3C3\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.113523636\", \"geneName\": \"SMIM40\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.8358\", \"geneName\": \"H3C2\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.84726\", \"geneName\": \"PRRC2B\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.120766137\", \"geneName\": \"HRURF\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.101927423\", \"geneName\": \"PANO1\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.122319436\", \"geneName\": \"RNF228\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.170487\", \"geneName\": \"ACTL10\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.2831\", \"geneName\": \"NPBWR1\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.114841035\", \"geneName\": \"entrez.114841035\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.100528062\", \"geneName\": \"ARMCX5-GPRASP2\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.100996717\", \"geneName\": \"NOTCH2NLC\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"geneId\": \"entrez.... (truncated)",
  "cypher" : "MATCH (g1:Gene)-[:GeneExpressedInTissue]->(t:Tissue)<-[:GeneExpressedInTissue]-(g2:Gene)\nWHERE toLower(g1.displayName) = 'msh6'\n  AND g2.primaryDomainId <> g1.primaryDomainId\n  AND t.primaryDomainId IN ['uberon.0002418','uberon.0001135','uberon.0001134','uberon.0001133','uberon.0001013']\nRETURN DISTINCT g2.primaryDomainId AS geneId, g2.displayName AS geneName, t.primaryDomainId AS tissueId, t.displayName AS tissueName;",
  "isCorrect" : false,
  "question" : "Find other genes that are expressed in the same tissues as the MSH6 gene.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer**  \nThe Immune System pathway contains several druggable proteins.  In the graph, the following UniProt‑identified proteins are linked to known DrugBank drugs:  \n\n- **IRAK3 (uniprot.Q9Y616)** – targets drugs such as Gilteritinib, Pacritinib, Midostaurin, Tamatinib, Fostamatinib, Pazopanib, Fedratinib, Nintedanib, Crizotinib, Sunitinib, and Gefitinib.  \n- **AAKB1 (uniprot.Q9Y478)** – targeted by Phenformin and Metformin.  \n- **TN13B (uniprot.Q9Y275)** – targeted by Belimumab.  \n- **HPSE (uniprot.Q9Y251)** – targeted by Amodiaquine.  \n- **AKT3 (uniprot.Q9Y243)** – targeted by Midostaurin and Ruboxistaurin.  \n- **KCC2A (uniprot.Q9UQM7)** – targeted by drugs including Nintedanib, Fedratinib, Tamatinib, Fostamatinib, Midostaurin, Tofacitinib, γ‑hydroxybutyric acid, and Sodium oxybate (among others).\n\n**Evidence**  \n- IRAK3 (uniprot.Q9Y616) – drug targets  \n- AAKB1 (uniprot.Q9Y478) – drug targets  \n- TN13B (uniprot.Q9Y275) – drug target  \n- HPSE (uniprot.Q9Y251) – drug target  \n- AKT3 (uniprot.Q9Y243) – drug target  \n- KCC2A (uniprot.Q9UQM7) – drug target  \n\n**Details**  \n\n| Protein (UniProt) | Protein Name | DrugBank ID | Drug Name |\n|-------------------|--------------|-------------|-----------|\n| Q9Y616 | IRAK3_HUMAN | DB12141 | Gilteritinib |\n| Q9Y616 | IRAK3_HUMAN | DB11697 | Pacritinib |\n| Q9Y616 | IRAK3_HUMAN | DB06595 | Midostaurin |\n| Q9Y616 | IRAK3_HUMAN | DB07159 | Tamatinib |\n| Q9Y616 | IRAK3_HUMAN | DB12010 | Fostamatinib |\n| Q9Y616 | IRAK3_HUMAN | DB06589 | Pazopanib |\n| Q9Y616 | IRAK3_HUMAN | DB12500 | Fedratinib |\n| Q9Y616 | IRAK3_HUMAN | DB09079 | Nintedanib |\n| Q9Y616 | IRAK3_HUMAN | DB08865 | Crizotinib |\n| Q9Y616 | IRAK3_HUMAN | DB01268 | Sunitinib |\n| Q9Y616 | IRAK3_HUMAN | DB00317 | Gefitinib |\n| Q9Y478 | AAKB1_HUMAN | DB00914 | Phenformin |\n| Q9Y478 | AAKB1_HUMAN | DB00331 | Metformin |\n| Q9Y275 | TN13B_HUMAN | DB08879 | Belimumab |\n| Q9Y251 | HPSE_HUMAN | DB00613 | Amodiaquine |\n| Q9Y243 | AKT3_HUMAN | DB06595 | Midostaurin |\n| Q9Y243 | AKT3_HUMAN | DB11829 | Ruboxistaurin |\n| Q9UQM7 | KCC2A_HUMAN | DB09079 | Nintedanib |\n| Q9UQM7 | KCC2A_HUMAN | DB12500 | Fedratinib |\n| Q9UQM7 | KCC2A_HUMAN | DB07159 | Tamatinib |\n| Q9UQM7 | KCC2A_HUMAN | DB12010 | Fostamatinib |\n| Q9UQM7 | KCC2A_HUMAN | DB06595 | Midostaurin |\n| Q9UQM7 | KCC2A_HUMAN | DB08895 | Tofacitinib |\n| Q9UQM7 | KCC2A_HUMAN | DB01440 | gamma‑Hydroxybutyric acid |\n| Q9UQM7 | KCC2A_HUMAN | DB09072 | Sodium oxybate |\n*(additional KCC2A drug associations continue beyond the shown data)*\n\nThese protein–drug pairs represent the known drug targets in the Immune System pathway according to the provided Neo4j result.",
  "context" : "[{\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB12141\", \"drugName\": \"Gilteritinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB11697\", \"drugName\": \"Pacritinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB06595\", \"drugName\": \"Midostaurin\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB07159\", \"drugName\": \"Tamatinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB12010\", \"drugName\": \"Fostamatinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB06589\", \"drugName\": \"Pazopanib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB12500\", \"drugName\": \"Fedratinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB09079\", \"drugName\": \"Nintedanib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB08865\", \"drugName\": \"Crizotinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB01268\", \"drugName\": \"Sunitinib\"}, {\"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"drugId\": \"drugbank.DB00317\", \"drugName\": \"Gefitinib\"}, {\"proteinId\": \"uniprot.Q9Y478\", \"proteinName\": \"AAKB1_HUMAN\", \"drugId\": \"drugbank.DB00914\", \"drugName\": \"Phenformin\"}, {\"proteinId\": \"uniprot.Q9Y478\", \"proteinName\": \"AAKB1_HUMAN\", \"drugId\": \"drugbank.DB00331\", \"drugName\": \"Metformin\"}, {\"proteinId\": \"uniprot.Q9Y275\", \"proteinName\": \"TN13B_HUMAN\", \"drugId\": \"drugbank.DB08879\", \"drugName\": \"Belimumab\"}, {\"proteinId\": \"uniprot.Q9Y251\", \"proteinName\": \"HPSE_HUMAN\", \"drugId\": \"drugbank.DB00613\", \"drugName\": \"Amodiaquine\"}, {\"proteinId\": \"uniprot.Q9Y243\", \"proteinName\": \"AKT3_HUMAN\", \"drugId\": \"drugbank.DB06595\", \"drugName\": \"Midostaurin\"}, {\"proteinId\": \"uniprot.Q9Y243\", \"proteinName\": \"AKT3_HUMAN\", \"drugId\": \"drugbank.DB11829\", \"drugName\": \"Ruboxistaurin\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB09079\", \"drugName\": \"Nintedanib\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB12500\", \"drugName\": \"Fedratinib\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB07159\", \"drugName\": \"Tamatinib\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB12010\", \"drugName\": \"Fostamatinib\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB06595\", \"drugName\": \"Midostaurin\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB08895\", \"drugName\": \"Tofacitinib\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB01440\", \"drugName\": \"gamma-Hydroxybutyric acid\"}, {\"proteinId\": \"uniprot.Q9UQM7\", \"proteinName\": \"KCC2A_HUMAN\", \"drugId\": \"drugbank.DB09072\", \"drugName\": \"Sodium oxybate\"}, {... (truncated)",
  "cypher" : "MATCH (path:Pathway {primaryDomainId:'reactome.R-HSA-168256'})\nMATCH (p:Protein)-[:ProteinInPathway]->(path)\nMATCH (d:Drug)-[:DrugHasTarget]->(p)\nRETURN DISTINCT p.primaryDomainId AS proteinId, p.displayName AS proteinName, d.primaryDomainId AS drugId, d.displayName AS drugName;",
  "isCorrect" : true,
  "question" : "What are the known drug targets within the 'Immune System' pathway?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer:  \nThe graph contains only the Innate Immune System pathway (Reactome R‑HSA‑168249). It lists several proteins and their interactions, such as DC1L1_HUMAN (UniProt Q9Y6G9) interacting with NEMO_HUMAN (Q9Y6K9), IRAK3_HUMAN (Q9Y616) interacting with NEMO, and several self‑interactions (e.g., DC1L1_HUMAN ↔ DC1L1_HUMAN, LY96_HUMAN ↔ LY96_HUMAN). No proteins or interactions from an Adaptive Immune System pathway are present in the data, so a direct comparison cannot be made.\n\nEvidence:  \n- DC1L1_HUMAN (uniprot.Q9Y6G9) – part of Innate pathway  \n- NEMO_HUMAN (uniprot.Q9Y6K9) – interacts with DC1L1_HUMAN and IRAK3_HUMAN  \n- IRAK3_HUMAN (uniprot.Q9Y616) – interacts with NEMO_HUMAN and self  \n- LY96_HUMAN (uniprot.Q9Y6Y9) – self‑interaction  \n- LTOR2_HUMAN (uniprot.Q9Y2Q5) – interacts with TPPC1_HUMAN (Q9Y5R8) and self  \n\nNext steps:  \n- Query the graph for the Adaptive Immune System pathway (e.g., Reactome R‑HSA‑xxxx) to retrieve its protein components and interactions.  \n- Compare the two sets of proteins and interactions once the adaptive data is available.",
  "context" : "[{\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6G9\", \"proteinName\": \"DC1L1_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y6K9\", \"interactingProteinName\": \"NEMO_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6G9\", \"proteinName\": \"DC1L1_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y6G9\", \"interactingProteinName\": \"DC1L1_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6Z7\", \"proteinName\": \"COL10_HUMAN\", \"interactingProteinId\": null, \"interactingProteinName\": null}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6Y9\", \"proteinName\": \"LY96_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y6Y9\", \"interactingProteinName\": \"LY96_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6X5\", \"proteinName\": \"ENPP4_HUMAN\", \"interactingProteinId\": null, \"interactingProteinName\": null}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y6W5\", \"proteinName\": \"WASF2_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y6W5\", \"interactingProteinName\": \"WASF2_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y6K9\", \"interactingProteinName\": \"NEMO_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y616\", \"proteinName\": \"IRAK3_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y616\", \"interactingProteinName\": \"IRAK3_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y5Z4\", \"proteinName\": \"HEBP2_HUMAN\", \"interactingProteinId\": null, \"interactingProteinName\": null}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y5R8\", \"proteinName\": \"TPPC1_HUMAN\", \"interactingProteinId\": null, \"interactingProteinName\": null}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y2Q5\", \"proteinName\": \"LTOR2_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y5R8\", \"interactingProteinName\": \"TPPC1_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"proteinId\": \"uniprot.Q9Y2Q5\", \"proteinName\": \"LTOR2_HUMAN\", \"interactingProteinId\": \"uniprot.Q9Y2Q5\", \"interactingProteinName\": \"LTOR2_HUMAN\"}, {\"pathwayType\": \"Innate\", \"pathwayId\": \"reactome.R-HSA-168249\", \"pathwayName\": \"Innate Immune System\", \"protein... (truncated)",
  "cypher" : "MATCH (pwInn:Pathway {primaryDomainId:'reactome.R-HSA-168249'})\nOPTIONAL MATCH (pInn:Protein)-[:ProteinInPathway]->(pwInn)\nOPTIONAL MATCH (pInn)-[:ProteinInteractsWithProtein]->(qInn:Protein)-[:ProteinInPathway]->(pwInn)\nRETURN\n  'Innate' AS pathwayType,\n  pwInn.primaryDomainId AS pathwayId,\n  pwInn.displayName AS pathwayName,\n  pInn.primaryDomainId AS proteinId,\n  pInn.displayName AS proteinName,\n  qInn.primaryDomainId AS interactingProteinId,\n  qInn.displayName AS interactingProteinName\nUNION ALL\nMATCH (pwAda:Pathway {primaryDomainId:'reactome.R-HSA-1280218'})\nOPTIONAL MATCH (pAda:Protein)-[:ProteinInPathway]->(pwAda)\nOPTIONAL MATCH (pAda)-[:ProteinInteractsWithProtein]->(qAda:Protein)-[:ProteinInPathway]->(pwAda)\nRETURN\n  'Adaptive' AS pathwayType,\n  pwAda.primaryDomainId AS pathwayId,\n  pwAda.displayName AS pathwayName,\n  pAda.primaryDomainId AS proteinId,\n  pAda.displayName AS proteinName,\n  qAda.primaryDomainId AS interactingProteinId,\n  qAda.displayName AS interactingProteinName",
  "isCorrect" : true,
  "question" : "What are the key differences between the 'Innate Immune System' and 'Adaptive Immune System' pathways in terms of protein components and their interactions?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAffectsGene]->(g:Gene)-[:ProteinEncodedByGene]->(p:Protein)-[:ProteinInPathway]->(path:Pathway)\nWHERE path.primaryDomainId IN ['reactome.R-HSA-9687139','reactome.R-HSA-9675126','reactome.R-HSA-69278','reactome.R-HSA-453276','reactome.R-HSA-9617828']\nMATCH (v)-[:VariantAssociatedWithDisorder]->(dis:Disorder)\nRETURN v.primaryDomainId AS variantId, v.alternativeSequence AS altSeq, v.position AS position, v.referenceSequence AS refSeq, v.variantType AS type,\n       g.primaryDomainId AS geneId, g.approvedSymbol AS geneSymbol,\n       path.primaryDomainId AS pathwayId, path.displayName AS pathwayName,\n       dis.primaryDomainId AS disorderId, dis.displayName AS disorderName;",
  "isCorrect" : true,
  "question" : "Are there any genomic variants known to affect genes involved in the 'Cell Cycle' pathway, and are these variants associated with specific disorders?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names or synonyms for the pathway, broaden the search to include related pathways or broader tissue categories, or relax any filtering criteria in the query.",
  "context" : "[]",
  "cypher" : "MATCH (pw:Pathway)-[:ProteinInPathway]->(p:Protein)-[:ProteinEncodedByGene]->(g:Gene)-[:GeneExpressedInTissue]->(t:Tissue)\nWHERE pw.primaryDomainId IN ['reactome.R-HSA-9013106','reactome.R-HSA-9012999','reactome.R-HSA-9035034','reactome.R-HSA-5666185','reactome.R-HSA-9013407']\nRETURN DISTINCT t.primaryDomainId AS tissueId, t.displayName AS tissueName",
  "isCorrect" : true,
  "question" : "What tissues express the genes associated with the 'RHO GTPase cycle' pathway?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nDrugs that target proteins in the *SARS‑CoV Infections* pathway are linked to a range of side effects. The most frequent are musculoskeletal complaints (myalgia, muscle pain, soreness), gastrointestinal symptoms (nausea, vomiting, indigestion), neurological symptoms (headache, cephalgia), and fever‑related effects (pyrexia, fever, elevated temperature).\n\n**Evidence**  \n- Myalgia (meddra.10028411) – musculoskeletal discomfort  \n- Nausea (meddra.10028813) – gastrointestinal upset  \n- Headache (meddra.10019211) – neurological symptom  \n- Fever (meddra.10016558) – pyrexia  \n\n**Details (selected side‑effect list)**  \n\n| Side‑Effect ID | Side‑Effect Name |\n|----------------|------------------|\n| meddra.10053156 | Musculoskeletal discomfort |\n| meddra.10033466 | Pain muscle |\n| meddra.10028287 | Muscle ache |\n| meddra.10028299 | Muscle discomfort |\n| meddra.10028361 | Muscular pain |\n| meddra.10028322 | Muscle pain |\n| meddra.10028362 | Muscular pains |\n| meddra.10018089 | Generalised muscle aches |\n| meddra.10028332 | Muscle soreness |\n| meddra.10028411 | Myalgia |\n| meddra.10062441 | Generalized muscle aches |\n| meddra.10028323 | Muscle pains |\n| meddra.10022123 | Injury NOS |\n| meddra.10044528 | Traumatic injury |\n| meddra.10022116 | Injury |\n| meddra.10000380 | Accidental injury |\n| meddra.10047706 | Vomiting NOS |\n| meddra.10047699 | Vomited |\n| meddra.10047700 | Vomiting |\n| meddra.10014542 | Emesis |\n| meddra.10033470 | Pain NOS |\n| meddra.10033371 | Pain |\n| meddra.10028822 | Nauseated |\n| meddra.10016361 | Feeling queasy |\n| meddra.10037730 | Queasy |\n| meddra.10028823 | Nauseous |\n| meddra.10028813 | Nausea |\n| meddra.10019198 | Head pain |\n| meddra.10033405 | Pain head |\n| meddra.10019211 | Headache |\n| meddra.10019218 | Headache NOS |\n| meddra.10008013 | Cephalgia |\n| meddra.10019231 | Headaches |\n| meddra.10037663 | Pyrexia NOS |\n| meddra.10005911 | Body temperature increased |\n| meddra.10073718 | Feverish |\n| meddra.10037668 | Pyrexial |\n| meddra.10037660 | Pyrexia |\n| meddra.10020083 | High temperature |\n| meddra.10016558 | Fever |\n| meddra.10043204 | Temperature elevation |\n| meddra.10021706 | Indigestion |",
  "context" : "[{\"sideEffectId\": \"meddra.10053156\", \"sideEffectName\": \"Musculoskeletal discomfort\"}, {\"sideEffectId\": \"meddra.10033466\", \"sideEffectName\": \"Pain muscle\"}, {\"sideEffectId\": \"meddra.10028287\", \"sideEffectName\": \"Muscle ache\"}, {\"sideEffectId\": \"meddra.10028299\", \"sideEffectName\": \"Muscle discomfort\"}, {\"sideEffectId\": \"meddra.10028361\", \"sideEffectName\": \"Muscular pain\"}, {\"sideEffectId\": \"meddra.10028322\", \"sideEffectName\": \"Muscle pain\"}, {\"sideEffectId\": \"meddra.10028362\", \"sideEffectName\": \"Muscular pains\"}, {\"sideEffectId\": \"meddra.10018089\", \"sideEffectName\": \"Generalised muscle aches\"}, {\"sideEffectId\": \"meddra.10028332\", \"sideEffectName\": \"Muscle soreness\"}, {\"sideEffectId\": \"meddra.10028411\", \"sideEffectName\": \"Myalgia\"}, {\"sideEffectId\": \"meddra.10062441\", \"sideEffectName\": \"Generalized muscle aches\"}, {\"sideEffectId\": \"meddra.10028323\", \"sideEffectName\": \"Muscle pains\"}, {\"sideEffectId\": \"meddra.10022123\", \"sideEffectName\": \"Injury NOS\"}, {\"sideEffectId\": \"meddra.10044528\", \"sideEffectName\": \"Traumatic injury\"}, {\"sideEffectId\": \"meddra.10022116\", \"sideEffectName\": \"Injury\"}, {\"sideEffectId\": \"meddra.10000380\", \"sideEffectName\": \"Accidental injury\"}, {\"sideEffectId\": \"meddra.10047706\", \"sideEffectName\": \"Vomiting NOS\"}, {\"sideEffectId\": \"meddra.10047699\", \"sideEffectName\": \"Vomited\"}, {\"sideEffectId\": \"meddra.10047700\", \"sideEffectName\": \"Vomiting\"}, {\"sideEffectId\": \"meddra.10014542\", \"sideEffectName\": \"Emesis\"}, {\"sideEffectId\": \"meddra.10033470\", \"sideEffectName\": \"Pain NOS\"}, {\"sideEffectId\": \"meddra.10033371\", \"sideEffectName\": \"Pain\"}, {\"sideEffectId\": \"meddra.10028822\", \"sideEffectName\": \"Nauseated\"}, {\"sideEffectId\": \"meddra.10016361\", \"sideEffectName\": \"Feeling queasy\"}, {\"sideEffectId\": \"meddra.10037730\", \"sideEffectName\": \"Queasy\"}, {\"sideEffectId\": \"meddra.10028823\", \"sideEffectName\": \"Nauseous\"}, {\"sideEffectId\": \"meddra.10028813\", \"sideEffectName\": \"Nausea\"}, {\"sideEffectId\": \"meddra.10019198\", \"sideEffectName\": \"Head pain\"}, {\"sideEffectId\": \"meddra.10033405\", \"sideEffectName\": \"Pain head\"}, {\"sideEffectId\": \"meddra.10019211\", \"sideEffectName\": \"Headache\"}, {\"sideEffectId\": \"meddra.10019218\", \"sideEffectName\": \"Headache NOS\"}, {\"sideEffectId\": \"meddra.10008013\", \"sideEffectName\": \"Cephalgia\"}, {\"sideEffectId\": \"meddra.10019231\", \"sideEffectName\": \"Headaches\"}, {\"sideEffectId\": \"meddra.10037663\", \"sideEffectName\": \"Pyrexia NOS\"}, {\"sideEffectId\": \"meddra.10005911\", \"sideEffectName\": \"Body temperature increased\"}, {\"sideEffectId\": \"meddra.10073718\", \"sideEffectName\": \"Feverish\"}, {\"sideEffectId\": \"meddra.10037668\", \"sideEffectName\": \"Pyrexial\"}, {\"sideEffectId\": \"meddra.10037660\", \"sideEffectName\": \"Pyrexia\"}, {\"sideEffectId\": \"meddra.10020083\", \"sideEffectName\": \"High temperature\"}, {\"sideEffectId\": \"meddra.10016558\", \"sideEffectName\": \"Fever\"}, {\"sideEffectId\": \"meddra.10043204\", \"sideEffectName\": \"Temperature elevation\"}, {\"sideEffectId\": \"meddra.10021706\", \"sideEffectName\": \"Indigestion\"}, {\"sideEffectId\": \"meddra.10013... (truncated)",
  "cypher" : "MATCH (pw:Pathway {primaryDomainId:'reactome.R-HSA-9679506'})\nMATCH (p:Protein)-[:ProteinInPathway]->(pw)\nMATCH (d:Drug)-[:DrugHasTarget]->(p)\nMATCH (d)-[:DrugHasSideEffect]->(se:SideEffect)\nRETURN DISTINCT se.primaryDomainId AS sideEffectId, se.displayName AS sideEffectName",
  "isCorrect" : true,
  "question" : "What are the side effects of drugs that target proteins within the 'SARS-CoV Infections' pathway?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (g:Gene {primaryDomainId:'entrez.672'}),\n      (p:Protein)-[:ProteinEncodedByGene]->(g),\n      (d:Drug)-[:DrugHasTarget]->(p),\n      (d)-[:DrugHasSideEffect]->(se:SideEffect)\nWHERE toLower(se.displayName) = toLower('Dizziness')\nRETURN d.primaryDomainId AS drugId,\n       d.displayName AS drugName,\n       se.primaryDomainId AS sideEffectId,\n       se.displayName AS sideEffectName,\n       g.primaryDomainId AS geneId,\n       g.displayName AS geneName;",
  "isCorrect" : false,
  "question" : "Is 'Dizziness' a reported side effect of any drugs targeting the protein encoded by the gene BRCA1?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe graph identifies 38 disorders that are linked to drugs that list vomiting as a side effect. These disorders span a wide range of conditions, including autoimmune diseases, cancers, cardiovascular disorders, infections, and psychiatric disorders.\n\n**Evidence**  \n- *relapsing‑remitting multiple sclerosis* (mondo.0005314)  \n- *rheumatoid arthritis* (mondo.0008383)  \n- *multiple sclerosis* (mondo.0005301)  \n- *metastatic melanoma* (mondo.0005191)  \n- *medullary thyroid gland carcinoma* (mondo.0015277)  \n- *renal cell carcinoma* (mondo.0005086)  \n- *hepatitis C virus infection* (mondo.0005231)  \n- *HIV infectious disease* (mondo.0005109)  \n- *Erdheim‑Chestert disease* (mondo.0018153)  \n- *thrombotic disease* (mondo.0000831)  \n- *thrombocytopenia* (mondo.0002049)  \n- *stroke disorder* (mondo.0005098)  \n- *myocardial ischemia* (mondo.0024644)  \n- *ischemic disease* (mondo.0005053)  \n- *coronary thrombosis* (mondo.0006716)  \n- *acute coronary syndrome* (mondo.0005542)  \n- *endometriosis* (mondo.0005133)  \n- *precocious puberty* (mondo.0000088)  \n- *skin basal cell carcinoma* (mondo.0005341)  \n- *pulmonary arterial hypertension* (mondo.0015924)  \n- *chronic thromboembolic pulmonary hypertension* (mondo.0013024)  \n- *marginal zone lymphoma* (mondo.0017604)  \n- *chronic graft versus host disease* (mondo.0020547)  \n- *mantle cell lymphoma* (mondo.0018876)  \n- *thyroid gland undifferentiated (anaplastic) carcinoma* (mondo.0006468)  \n- *lung neoplasm* (mondo.0021117)  \n- *non‑small cell lung carcinoma* (mondo.0005233)  \n- *urea cycle disorder* (mondo.0004739)  \n- *soft tissue sarcoma* (mondo.0018078)  \n- *major depressive disorder* (mondo.0002009)  \n- *epilepsy, idiopathic generalized, susceptibility to, 1* (mondo.0010918)  \n- *staphylococcus aureus pneumonia* (mondo.0041879)  \n- *streptococcal pneumonia* (mondo.0005972)  \n- *staphylococcus aureus infection* (mondo.0005545)  \n- *rhinoscleroma* (mondo.0005945)  \n- *escherichia coli infection* (mondo.0020920)  \n- *mature T‑cell and NK‑cell non‑Hodgkin lymphoma* (mondo.0000430)  \n- *tuberous sclerosis* (mondo.0001734)\n\n**Details**\n\n| Disorder ID | Disorder Name |\n|-------------|---------------|\n| mondo.0005314 | relapsing‑remitting multiple sclerosis |\n| mondo.0008383 | rheumatoid arthritis |\n| mondo.0005301 | multiple sclerosis |\n| mondo.0005191 | metastatic melanoma |\n| mondo.0015277 | medullary thyroid gland carcinoma |\n| mondo.0005086 | renal cell carcinoma |\n| mondo.0005231 | hepatitis C virus infection |\n| mondo.0005109 | HIV infectious disease |\n| mondo.0018153 | Erdheim‑Chestert disease |\n| mondo.0000831 | thrombotic disease |\n| mondo.0002049 | thrombocytopenia |\n| mondo.0005098 | stroke disorder |\n| mondo.0024644 | myocardial ischemia |\n| mondo.0005053 | ischemic disease |\n| mondo.0006716 | coronary thrombosis |\n| mondo.0005542 | acute coronary syndrome |\n| mondo.0005133 | endometriosis |\n| mondo.0000088 | precocious puberty |\n| mondo.0005341 | skin basal cell carcinoma |\n| mondo.0015924 | pulmonary arterial hypertension |\n| mondo.0013024 | chronic thromboembolic pulmonary hypertension |\n| mondo.0017604 | marginal zone lymphoma |\n| mondo.0020547 | chronic graft versus host disease |\n| mondo.0018876 | mantle cell lymphoma |\n| mondo.0006468 | thyroid gland undifferentiated (anaplastic) carcinoma |\n| mondo.0021117 | lung neoplasm |\n| mondo.0005233 | non‑small cell lung carcinoma |\n| mondo.0004739 | urea cycle disorder |\n| mondo.0018078 | soft tissue sarcoma |\n| mondo.0002009 | major depressive disorder |\n| mondo.0010918 | epilepsy, idiopathic generalized, susceptibility to, 1 |\n| mondo.0041879 | staphylococcus aureus pneumonia |\n| mondo.0005972 | streptococcal pneumonia |\n| mondo.0005545 | staphylococcus aureus infection |\n| mondo.0005945 | rhinoscleroma |\n| mondo.0020920 | escherichia coli infection |\n| mondo.0000430 | mature T‑cell and NK‑cell non‑Hodgkin lymphoma |\n| mondo.0001734 | tuberous sclerosis |\n\n*(The list is truncated after `mondo.0004989` in the supplied data.)*",
  "context" : "[{\"disorderId\": \"mondo.0005314\", \"disorderName\": \"relapsing-remitting multiple sclerosis\"}, {\"disorderId\": \"mondo.0008383\", \"disorderName\": \"rheumatoid arthritis\"}, {\"disorderId\": \"mondo.0005301\", \"disorderName\": \"multiple sclerosis\"}, {\"disorderId\": \"mondo.0005191\", \"disorderName\": \"metastatic melanoma\"}, {\"disorderId\": \"mondo.0015277\", \"disorderName\": \"medullary thyroid gland carcinoma\"}, {\"disorderId\": \"mondo.0005086\", \"disorderName\": \"renal cell carcinoma\"}, {\"disorderId\": \"mondo.0005231\", \"disorderName\": \"hepatitis C virus infection\"}, {\"disorderId\": \"mondo.0005109\", \"disorderName\": \"HIV infectious disease\"}, {\"disorderId\": \"mondo.0018153\", \"disorderName\": \"Erdheim-Chester disease\"}, {\"disorderId\": \"mondo.0000831\", \"disorderName\": \"thrombotic disease\"}, {\"disorderId\": \"mondo.0002049\", \"disorderName\": \"thrombocytopenia\"}, {\"disorderId\": \"mondo.0005098\", \"disorderName\": \"stroke disorder\"}, {\"disorderId\": \"mondo.0024644\", \"disorderName\": \"myocardial ischemia\"}, {\"disorderId\": \"mondo.0005053\", \"disorderName\": \"ischemic disease\"}, {\"disorderId\": \"mondo.0006716\", \"disorderName\": \"coronary thrombosis\"}, {\"disorderId\": \"mondo.0005542\", \"disorderName\": \"acute coronary syndrome\"}, {\"disorderId\": \"mondo.0005133\", \"disorderName\": \"endometriosis\"}, {\"disorderId\": \"mondo.0000088\", \"disorderName\": \"precocious puberty\"}, {\"disorderId\": \"mondo.0005341\", \"disorderName\": \"skin basal cell carcinoma\"}, {\"disorderId\": \"mondo.0015924\", \"disorderName\": \"pulmonary arterial hypertension\"}, {\"disorderId\": \"mondo.0013024\", \"disorderName\": \"chronic thromboembolic pulmonary hypertension\"}, {\"disorderId\": \"mondo.0017604\", \"disorderName\": \"marginal zone lymphoma\"}, {\"disorderId\": \"mondo.0020547\", \"disorderName\": \"chronic graft versus host disease\"}, {\"disorderId\": \"mondo.0018876\", \"disorderName\": \"mantle cell lymphoma\"}, {\"disorderId\": \"mondo.0006468\", \"disorderName\": \"thyroid gland undifferentiated (anaplastic) carcinoma\"}, {\"disorderId\": \"mondo.0021117\", \"disorderName\": \"lung neoplasm\"}, {\"disorderId\": \"mondo.0005233\", \"disorderName\": \"non-small cell lung carcinoma\"}, {\"disorderId\": \"mondo.0004739\", \"disorderName\": \"urea cycle disorder\"}, {\"disorderId\": \"mondo.0018078\", \"disorderName\": \"soft tissue sarcoma\"}, {\"disorderId\": \"mondo.0002009\", \"disorderName\": \"major depressive disorder\"}, {\"disorderId\": \"mondo.0010918\", \"disorderName\": \"epilepsy, idiopathic generalized, susceptibility to, 1\"}, {\"disorderId\": \"mondo.0041879\", \"disorderName\": \"staphylococcus aureus pneumonia\"}, {\"disorderId\": \"mondo.0005972\", \"disorderName\": \"streptococcal pneumonia\"}, {\"disorderId\": \"mondo.0005545\", \"disorderName\": \"staphylococcus aureus infection\"}, {\"disorderId\": \"mondo.0005945\", \"disorderName\": \"rhinoscleroma\"}, {\"disorderId\": \"mondo.0020920\", \"disorderName\": \"escherichia coli infection\"}, {\"disorderId\": \"mondo.0000430\", \"disorderName\": \"mature T-cell and NK-cell non-Hodgkin lymphoma\"}, {\"disorderId\": \"mondo.0001734\", \"disorderName\": \"tuberous sclerosis\"}, {\"disorderId\": \"mondo.0004989\", ... (truncated)",
  "cypher" : "MATCH (d:Drug)-[:DrugHasSideEffect]->(se:SideEffect)\nWHERE se.primaryDomainId IN ['meddra.10004682','meddra.10034716','meddra.10047700','meddra.10048356','meddra.10047706']\nMATCH (d)-[:DrugHasIndication]->(dis:Disorder)\nRETURN DISTINCT dis.primaryDomainId AS disorderId, dis.displayName AS disorderName",
  "isCorrect" : false,
  "question" : "List all disorders associated with drugs that have 'Vomiting' as a side effect.",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nThe graph distinguishes *Dermatitis* (MEDDRA 10012431) and *Skin rash* (MEDDRA 10040913) as separate side‑effect terms.  *Dermatitis* has no linked phenotype in the data, while *Skin rash* is associated with the HPO term HPO:0000988.  The `samePhenotype` field is null, indicating no evidence that the two terms represent the same clinical presentation.\n\n**Evidence:**\n- Dermatitis (MEDDRA:10012431) – side‑effect term  \n- Skin rash (MEDDRA:10040913) – side‑effect term  \n- Skin rash (HPO:0000988) – phenotype association  \n\n**Details**\n\n| Side‑Effect | MEDDRA ID | HPO Phenotype |\n|-------------|-----------|---------------|\n| Dermatitis | meddra.10012431 | — |\n| Skin rash   | meddra.10040913 | hpo.0000988 |\n\nThe lack of a shared phenotype mapping suggests that *Dermatitis* and *Skin rash* are not considered identical in this knowledge graph.",
  "context" : "[{\"se1Id\": \"meddra.10012431\", \"se1Name\": \"Dermatitis\", \"ph1Id\": null, \"ph1Name\": null, \"se2Id\": \"meddra.10040913\", \"se2Name\": \"Skin rash\", \"ph2Id\": \"hpo.0000988\", \"ph2Name\": \"Skin rash\", \"samePhenotype\": null}]",
  "cypher" : "MATCH (se1:SideEffect)\nWHERE toLower(se1.displayName) = toLower('Dermatitis')\nOPTIONAL MATCH (se1)-[:SideEffectSameAsPhenotype]->(ph1:Phenotype)\nMATCH (se2:SideEffect)\nWHERE toLower(se2.displayName) = toLower('Skin rash')\nOPTIONAL MATCH (se2)-[:SideEffectSameAsPhenotype]->(ph2:Phenotype)\nRETURN se1.primaryDomainId AS se1Id,\n       se1.displayName AS se1Name,\n       ph1.primaryDomainId AS ph1Id,\n       ph1.displayName AS ph1Name,\n       se2.primaryDomainId AS se2Id,\n       se2.displayName AS se2Name,\n       ph2.primaryDomainId AS ph2Id,\n       ph2.displayName AS ph2Name,\n       (ph1.primaryDomainId = ph2.primaryDomainId) AS samePhenotype;",
  "isCorrect" : true,
  "question" : "Are 'Dermatitis' and 'Skin rash' considered the same side effect, or are there subtle differences in their clinical presentation?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "Answer: No matching records were found in the knowledge graph for this question.  \nEvidence: None.  \nNext steps: Try alternative names/synonyms, broaden the disorder/drug scope, or relax filters.",
  "context" : "[]",
  "cypher" : "MATCH (v:GenomicVariant)-[:VariantAffectsGene]->(g:Gene)-[:ProteinEncodedByGene]->(p:Protein)-[:DrugHasTarget]->(d:Drug)-[:DrugHasSideEffect]->(se:SideEffect)\nWHERE se.primaryDomainId IN ['meddra.10074033','meddra.10022093','meddra.10052576','meddra.10037092','meddra.10018123']\nRETURN v.primaryDomainId AS variantId,\n       v.displayName AS variantName,\n       v.chromosome,\n       v.position,\n       v.variantType,\n       v.alternativeSequence,\n       v.referenceSequence;",
  "isCorrect" : true,
  "question" : "Which genomic variants are associated with increased risk of experiencing 'Pruritus' as a drug side effect?",
  "attempt" : 0,
  "fallback" : false
}, {
  "answer" : "**Answer:**  \nYes. The graph records several drugs that are associated with “Abdominal pain NOS” occurring in specific tissues.  The drugs listed—**Dabrafenib, Cabozantinib, Triptorelin, Cobicistat, Ponatinib, and Ulipristal**—each have side‑effect entries linked to **adipose tissue, cardiac muscle tissue, and smooth muscle tissue**.\n\n**Evidence**  \n• Dabrafenib (drugbank.DB08912) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n• Cabozantinib (drugbank.DB08875) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n• Triptorelin (drugbank.DB06825) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n• Cobicistat (drugbank.DB09065) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n• Ponatinib (drugbank.DB08901) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n• Ulipristal (drugbank.DB08867) – abdominal pain NOS in adipose tissue, cardiac muscle tissue, smooth muscle tissue  \n\n**Details**\n\n| Drug (DrugBank ID) | Tissue (UBERON ID) | Tissue name |\n|--------------------|---------------------|-------------|\n| Dabrafenib (DB08912) | UBERON:0001013 | adipose tissue |\n| Dabrafenib (DB08912) | UBERON:0001133 | cardiac muscle tissue |\n| Dabrafenib (DB08912) | UBERON:0001135 | smooth muscle tissue |\n| Cabozantinib (DB08875) | UBERON:0001013 | adipose tissue |\n| Cabozantinib (DB08875) | UBERON:0001133 | cardiac muscle tissue |\n| Cabozantinib (DB08875) | UBERON:0001135 | smooth muscle tissue |\n| Triptorelin (DB06825) | UBERON:0001013 | adipose tissue |\n| Triptorelin (DB06825) | UBERON:0001133 | cardiac muscle tissue |\n| Triptorelin (DB06825) | UBERON:0001135 | smooth muscle tissue |\n| Cobicistat (DB09065) | UBERON:0001013 | adipose tissue |\n| Cobicistat (DB09065) | UBERON:0001133 | cardiac muscle tissue |\n| Cobicistat (DB09065) | UBERON:0001135 | smooth muscle tissue |\n| Ponatinib (DB08901) | UBERON:0001013 | adipose tissue |\n| Ponatinib (DB08901) | UBERON:0001133 | cardiac muscle tissue |\n| Ponatinib (DB08901) | UBERON:0001135 | smooth muscle tissue |\n| Ulipristal (DB08867) | UBERON:0001013 | adipose tissue |\n| Ulipristal (DB08867) | UBERON:0001133 | cardiac muscle tissue |\n| Ulipristal (DB08867) | UBERON:0001135 | smooth muscle tissue |\n\n*(The graph also contains a record for Ivacaftor, but the provided data is truncated.)*",
  "context" : "[{\"drugId\": \"drugbank.DB08912\", \"drugName\": \"Dabrafenib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB08912\", \"drugName\": \"Dabrafenib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB08912\", \"drugName\": \"Dabrafenib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB08875\", \"drugName\": \"Cabozantinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB08875\", \"drugName\": \"Cabozantinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB08875\", \"drugName\": \"Cabozantinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB06825\", \"drugName\": \"Triptorelin\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB06825\", \"drugName\": \"Triptorelin\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB06825\", \"drugName\": \"Triptorelin\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB09065\", \"drugName\": \"Cobicistat\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB09065\", \"drugName\": \"Cobicistat\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB09065\", \"drugName\": \"Cobicistat\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB08901\", \"drugName\": \"Ponatinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB08901\", \"drugName\": \"Ponatinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB08901\", \"drugName\": \"Ponatinib\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB08867\", \"drugName\": \"Ulipristal\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001013\", \"tissueName\": \"adipose tissue\"}, {\"drugId\": \"drugbank.DB08867\", \"drugName\": \"Ulipristal\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001133\", \"tissueName\": \"cardiac muscle tissue\"}, {\"drugId\": \"drugbank.DB08867\", \"drugName\": \"Ulipristal\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"uberon.0001135\", \"tissueName\": \"smooth muscle tissue\"}, {\"drugId\": \"drugbank.DB08820\", \"drugName\": \"Ivacaftor\", \"sideEffect\": \"Abdominal pain NOS\", \"tissueId\": \"ub... (truncated)",
  "cypher" : "MATCH (d:Drug)-[:DrugHasSideEffect]->(se:SideEffect)\nWHERE toLower(se.displayName) = toLower('Abdominal pain NOS')\nOPTIONAL MATCH (d)-[:DrugHasTarget]->(p:Protein)-[:ProteinExpressedInTissue]->(t:Tissue)\nWHERE t.primaryDomainId IN ['uberon.0002418','uberon.0001135','uberone.0001134','uberon.0001013','uberon.0001133']\nRETURN DISTINCT d.primaryDomainId AS drugId,\n               d.displayName AS drugName,\n               se.displayName AS sideEffect,\n               t.primaryDomainId AS tissueId,\n               t.displayName AS tissueName;",
  "isCorrect" : true,
  "question" : "Are there any drugs known to cause 'Abdominal pain NOS' in specific tissues or populations?",
  "attempt" : 0,
  "fallback" : false
} ]